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Abstract
AD is characterized by the presence of two kinds of lesions in the brain:
neurofibrillary tangles and senile plaques (SP) containing a core of amyloid beta
(Ab) aggregates. Ab peptide is obtained from the amyloidogenic cleavage of a
larger precursor, the amyloid precursor protein (APP). Since its identification, a
huge effort has been made in order to further understand the metabolism and
the function of APP. Among others, a role in regulation of gene transcription is
allocated to the c-terminal fragment of APP (AICD) but this hypothesis remains
matter of debate. During my PhD, we investigated target genes of APP using a
model of mice knock-out for APP gene. By comparing transcripts coming from
APP +/+ and APP -/- astrocytes we discovered that the transcription of Egr-1 was
regulated by APP. Egr-1 belongs of the immediate early genes (IEG) family of
transcription factors involved in memory formation making it a good candidate for
further investigations. As Egr-1 is known to be regula...
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SUMMARY 
Alzheimer’s disease (AD) is the most common form of dementia, affecting more than 30% of the people over 
85 years.  This incurable neurological disorder slowly destroys memory and thinking skills and seriously 
interferes with the social activity of the patients. The long progressive course of AD starts with loss of 
neurons in the hippocampus involved in memory and in the cerebral cortex, followed by a progressive 
atrophy of the whole brain. 
AD is characterized by the presence of two kinds of lesions in the brain:  neurofibrillary tangles and senile 
plaques (SP) containing a core of amyloid beta (Aβ) aggregates. Aβ peptide is obtained from the 
amyloidogenic cleavage of a larger precursor, the amyloid precursor protein (APP). Since its identification, a 
huge effort has been made in order to further understand the metabolism and the function of APP. Among 
others, a role in regulation of gene transcription is allocated to the c-terminal fragment of APP (AICD) but 
this hypothesis remains matter of debate.  
During my PhD, we investigated target genes of APP using a model of mice knock-out for APP gene. By 
comparing transcripts coming from APP +/+ and APP -/- astrocytes we discovered that the transcription of 
Egr-1 was regulated by APP. Egr-1 belongs of the immediate early genes (IEG) family of transcription factors 
involved in memory formation making it a good candidate for further investigations. As Egr-1 is known to be 
regulated by histone acetylation, we focused our study on this type of epigenetic modification. Such 
addition of acetyl groups on lysines located on histone tails has a positive impact on gene transcription as it 
let the chromatin in an opened status.  
By studying primary culture of APP+/+ and APP-/- neurons, we observed that Egr-1 transcription was up-
regulated in absence of APP. Further analyzes of the promoter region of Egr-1 gene by chromatin 
immunoprecipitation (ChIP) showed that the level of histone H4 accetylation was increased in APP-/- 
neurons, arguing for an epigenetic regulation by APP. Using ChIP analysis combined with pharmacological 
treatment we demonstrated that this regulation was occurring in an AICD independent way. 
Later, we moved to a model of prefrontal (PF) cortex of APP+/+ and APP-/-mice, where we showed that Egr-
1 expression together with other IEGs like c-Fos, Bdnf and Arc were also upregulated in APP -/-. This increase 
of expression was followed by a greater enrichment of histone H4 acetylation at the promoter of Egr-1, c-
Fos and BDNF.  Deciphering the molecular mechanisms underlying this regulation, we observed that APP 
dependent regulation of Egr-1 depended of the binding of the neuronal induced transcription factor CREB 
while APP affected c-Fos expression by increasing the recruitment of a histone deacetylase (HDAC) on its 
promoter. 
Finally, we assessed the physiological relevance of this regulation by measuring the induction of c-Fos and 
Egr-1 after exposition to novelty, a stimulus described as fostering expression of these IEGs and important to 
initiate the first step of event underlying memory formation.   
We report that APP -/- mice were not able to induce properly c-Fos and Egr-1 in PF cortex after novelty 
exposure, suggesting a major role of APP in regulation of IEGs transcription mediating neuronal plasticity.  
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INTRODUCTION 
.  
I. Alzheimer’s	disease	
A. Pathology	
 
Alzheimer’s disease (AD) is an irreversible neurological disorder characterized by a progressive 
deterioration of cognitive functions that encompass thinking, remembering and reasoning. In 
addition, AD patients suffer  functional disabilities like visual and language declines and 
neuropsychiatric symptoms such as depression, apathy and aggressiveness (Dillon et al., 2013; 
Querfurth and LaFerla, 2010).  All those symptoms occur generally after the age of 60 years , more 
than 10 years after the appearance of brain damages caused by neuropathological events. Three 
stages occurs in AD : the earliest is asymptomatic, the middle stage called MCI (Mild cognitive 
impairements) is the stage in which first symptoms and changes in personality occur, till the third 
and last stage that leads to death within 3 to 9 years following diagnosis. Even if some medication 
helps maintenance of memory (by acting through neurotransmitters action), no treatment exists 
to slow down or cure the disease (LaFerla et al., 2007).   
B. Epidemiology		
Alzheimer’s disease is the most common form of dementia. The prevalence of the illness is 
estimated at 24 million worldwide (Prince et al., 2013).  As population aging is in constant 
progression in our societies, frequency could double in the next 30 years creating a real society 
burden. The incidence rate of AD is around 8.8 per 1000 in Western countries and this rate double 
every 5 years after 65 years, with a special progression between 70 and 80 years  (Querfurth and 
LaFerla, 2010). In Belgium, around 190 000 persons suffer dementia, at least 150 000 with AD. 
C. Etiology		
Sporadic forms of AD count for more than 95% of the cases. Even if there is no specific triggering 
factor known to induce the illness, some environmental factors as cerebrovascular diseases, 
hypertension or type II diabetes are described as favoring AD while a good cognitive reserve, low 
fat diet and physical activity could have a protective effect (Mayeux and Stern, 2012). 
  Introduction 
18 
 
Familial forms of AD (FAD) are due to mutations on three genes that have been firmly identified to 
be implicated in early-onset autosomal dominant AD: the Amyloid precursor protein (APP) gene, 
and genes encoding proteins involved in the cleavage of APP, presenilin 1 & presenilin 2 (PSEN1, 
PSEN2). Although mutations in these genes account for only about 1% of cases, their identification 
has been crucial to understand the molecular mechanisms of AD.  For the more common complex 
late-onset AD, the ε-4 allele of the gene encoding apolipoprotein E (APOE) has been recognized as 
a major genetic risk factor (Alonso Vilatela et al., 2012).   
D. Historic of AD 
In 1901, the German neuropsychiatrist Aloïs Alzheimer admitted a 51 years old patient named 
Auguste D. in Frankfurt hospital. The patient showed different symptoms of mental illness as 
memory loss, delusions and hallucinations. Following post mortem examination of her brain, 
Alzheimer identified two kinds of abnormal lesions that will later be admitted as the major 
hallmarks of the illness, called neurofibrillary tangles and senile plaques, and better identified 
thanks to the silver staining developed by Bielschowsky few years before. In November 1906, 
during the Society of Southwest German Psychiatrists meeting in Tübingen, Aloïs Alzheimer 
presented his results about the clinical and neuropathological characteristics of the disease that 
will be named after him in the future. The structure in filaments of the plaques and the 
neurofibrillary tangles (NFT) will be revealed in the 60’s thanks to electron microscopy (Kidd, 1964; 
Terry, 1963). The composition of the plaques and the identification of amyloid beta (Aβ) peptide as 
the major component will be discovered in 1984 by Glenner (Glenner and Wong, 1984) while Tau 
protein, constitutive of paired helical filaments of neurofibrillary tangles, was identified in 1985 
(Brion et al., 1985).  
E. Histopathological hallmarks of AD 
Neurofibrillary tangles 
 
Neurofibrillary tangles are intraneuronal inclusions composed of paired helical filaments (PHF) 
containing the Tau protein in hyperphosphorylated state (Figure 1). Presence of neurofibrillary 
tangles is mainly detected in hippocampus, entorhinal cortex, and amygdala of AD patient brain, 
but is also observed in other illness called tauopathies. PHF are described as fibrils of around 10nm 
of diameters in electron microscopy (Maccioni et al., 2001).  Evidence of Tau presence in PHF was 
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given by Brion et al. who were the first to show that antibody raised against the microtubule 
associated Tau protein labeled the core of NFT (Brion et al., 1985).  
Tau is a soluble microtubule-associated protein (MAP) encoded by the single MAPT gene. The 
primary transcript is alternatively spliced to produce 6 major isoforms expressed in the central 
nervous system (Medina and Avila, 2014; Trabzuni et al., 2012). Tau belongs to phosphoprotein 
family and is found mainly in axon of neurons. Association between Tau and tubulin enables a 
modulation of axonal stability and transport of vesicles by regulating microtubule assembly and 
dynamic behavior. Equilibrium between the phosporylated and dephosphorylated states of Tau 
modulating the cytoskeleton stability is impaired in AD where Tau is hyperphosphorylated. This 
hyperphosphorylation of Tau leads to its detachment from microtubules, which depolymerize 
impairing their functions and axonal transport.  Hyperphoshorylation of Tau also leads to its self-
association in paired helical filaments. Regulation of Tau phosphorylation occurs through 
numerous kinases of which GSK3β and Cdk5 are the two major ones able to phosphorylate the 
protein on many of the 30 phosphorylation sites described (Geschwind, 2003; Grundke-Iqbal et al., 
1986; Maccioni et al., 2001; Querfurth and LaFerla, 2010).  
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 Figure 1 :A. Formation of neurofibrillary tangles (adapted from Citron)(Citron, 2010) B. Neurofibrillary 
tangles in Bielschowsky silver stain (Perl, 2010) C. Tangle in a hippocampal pyramidal neuron on 
hematoxylin and eosin stain (Serrano-Pozo et al., 2011). D. Immunohistochemistry of tau protein. 
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Senile Plaques 
Senile plaques (SP) are extracellular spherical lesions with a diameter of around 50 to 200 
micrometer (Figure 2). The core of SP is mainly composed by the amyloid β peptide of 39 to 42 
amino acid residues obtained by the beta and gamma cleavage of its precursors, the Amyloid 
Precursor Protein (Glenner and Wong, 1984; Masters et al., 1985). Even if SP are one of the two 
hallmarks of AD, those lesions are also found in non-AD patients leading to other forms of 
dementia. Aβ 42 is the most common isoform of amyloid β found is SP and is associated with 
many other molecules such as ApoE, aluminum, acute-phase proteins such as α-antichymotrypsin, 
α2-macroglobulin and later with activated microglia and reactive astrocytes. This association leads 
to a local inflammatory cascade involving the release of cytokines, ROS, nitrogen intermediates 
and to neuronal loss. Aβ is prone to self-aggregate spontaneously into insoluble oligomers 
(containing two to six peptides) or in fibers formed by beta sheet of fibrillar Aβ. The different 
forms seem to coexist in a dynamic equilibrium in AD brains (Armstrong, 2009; LaFerla et al., 2007; 
Turner et al., 2003).  
A 
 
 
 
 
 
     B    C 
 
 
 
 
 
Figure 2 : A. Amyloid plaques formation from APP cleavage to accumulation of Aβ into senile 
plaques (adapted from Citron-(Citron, 2010) B. Senile plaques Bielschowski silver stain. C. Senile 
plaques in temporal cortex of AD patient. (immunohistochemical anti-Aβ staining) (Perl, 2010). 
  Introduction 
21 
 
F. The Amyloid Precursor Protein 
Gene description 
APP gene is located on chromosome 21 (21d21.2-3)(Kang et al., 1987). Alternative splicing of APP 
pre-mRNA can produce 10 different isoforms, among them APP695, APP751 and APP770 are 
predominant.  APP 695 is obtained by alternative splicing of exons 7-8, and lacks the Kunitz-type 
proteolysis domain (KPI). It is largely found in central nervous system, and is neuronal specific 
(Thinakaran and Koo, 2008) . On the contrary, APP 751 is found in minority in neurons but is 
predominant in astrocytes, glial cells and in the rest of the body where its expression is ubiquitous.  
APP protein 
APP is a member of an evolutionary conserved family that regroups among others, the APL1 from 
Caenorhabditis elegans  (Daigle and Li, 1993), APPL in Drosophila (Luo et al., 1990; Martin-Morris 
and White, 1990), appa and appb in zebrafish (Musa et al., 2001). In mammals, this family includes 
APP itself and APP like protein 1 and 2 (APLP1& APLP2). Some regions as the E1, E2 and the 
YENPTY motif of the extracellular tail are the most conserved in evolution (Coulson et al., 2000). 
Despite those sequences similarities, APLPs lack the Aβ domain and do not produce it. 
APP protein is a large transmembrane protein with a big extracellular N-terminal end, a single 
transmembrane domain, followed by a short intracellular domain (structure described in figure 3). 
APP contains two domains of defined secondary structure (E1 &E2), several binding domains for 
metal ions (Copper, Zinc), as well as Heparin/ F-spondin /collagen and a G0 binding domain and a 
large acidic region (the KPI) followed by two glycosylation sites and two internalization sequences. 
The Aβ sequence overlaps extracellular and transmembrane regions, while AICD is located at C-
terminal end.  
 
 
 
 
 
 
Figure 3 : Structure of the Amyloid precursor protein  
  Introduction 
22 
 
APP metabolism  
Generation of Aβ is closely related to APP metabolism. Aβ is produced during the so called 
“amyloidogenic pathway”. During this catabolic pathway, APP is firstly cleaved by β secretase to 
release the fragment soluble β APP  (sβAPP), then processed by the γ secretase complex that 
enables the production of Aβ and a small intracellular peptide, the APP Intracellular Domain 
(AICD). However, the major pathway by which APP is processed is “non-amyloidogenic”. It cleaves 
APP within the Aβ sequence, impairing its production. The α cleavage of APP by α secretase leads 
to the production of the soluble αAPP (sαAPP), which is sequentially cleaved by the same γ 
secretase complex releasing AICD and a small peptide called P3 (Zhang et al., 2012) (figure 4).  
Even if the amyloidogenic pathway is not dominant in neurons, β secretase is largely expressed 
and the release of Aβ occurs also in physiological conditions. In all other cell types, non-
amyloidogenic pathway largely prevails. α secretases are metalloproteases/ desintigrin belonging 
to the ADAM family, ADAM 10 and ADAM 17 being the most usual to cleave APP.  β secretases are 
aspartyl proteases as BACE1 while γsecretase are composed of a large multiproteic complex 
containing Aph-1, Nicastrine, Pen-2 and one of the presenilin (PS1/PS2) (Haass, 2004). 
 
 
 
 
 
 
 
 
 
 
Figure 4 : APP processing by the amyloidogenic or the non-amyloidogenic pathway 
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APP trafficking  
In neurons, APP protein is localized at dendrites, soma and synapses. Synthesis of APP is initiated 
in the endoplasmic reticulum. Hence, part of APP is translocated via the transgolgi network (TGN) 
to reach the cell surface, whereas another part is directly transported to the endosomal 
compartment. On the cell surface, APP is internalized by endocytosis (clatrhine mediated). Vesicles 
containing internalized APP, called endosomes, move through endocytic and recycling pathways to 
reach TGN or the cell surface. A fraction of APP is also degraded in late endosomes (Figure5). 
Obviously, APP processing can only occurs when secretases and APP are colocalized in the same 
cellular compartment. The non amyloidogenic pathway occurs mainly at cell surface, while β 
cleavage by BACE1 occurs in the endosomes. The newly formed Aβ is further released in 
extracellular medium after vesicle recycling, or directly degraded (Choy et al., 2012; Haass et al., 
2012; Müller and Zheng, 2012; O'Brien and Wong, 2011).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5 : Intraneuronal  APP trafficking. After synthesis and transfer in the Golgi, mature APP (red) 
is transported to the axon through the secretory pathway (A). At the plasma membrane, inserted 
APP is internalized by endocytosis to reach endosomes (B).  Endocytic APP (purple) is then recycled 
to the TGN (C)  where Aβ is produced. Biosynthetic pool of APP (red) can also traffic directly into the 
endosomes (D) or be degraded in the lysosomes  (Choy et al., 2012). 
  Introduction 
24 
 
G. Functions of APP  
APP by itself or via its multiple fragments exerts many functions in neurons.  Here is a short review 
of roles attributed to each of them.  
Full length APP  
Cell adhesion  
• Cell-matrix adhesion: APP has been showed to interact with extracellular matrix 
components as heparin, collagen type I, laminin (Beher et al., 1996; Clarris et al., 1997; 
Kibbey et al., 1993). 
• Cell-cell adhesion:  APP is able to form homo or hetero dimers via the E1 domain or the 
transmembrane GxxxG motif. The formation of antiparallel dimers of APP occurs also via 
the E2 domain. Those interactions could facilitate cell-cell adhesion and modulate γ 
secretase cleavage (Ben Khalifa et al., 2012; Richter et al., 2010). 
• Synaptic adhesion: Interaction of APP with Mint/X11 and calcium/calmodulin-dependent 
serine kinase-related protein (CASK) are similar of two well-known synaptic adhesion 
molecules neurexin and CASK, suggesting a role of APP in synaptic adhesion. Indeed APP, 
via its GENPTY motif, is able to make transcellular interaction that can affects 
synaptogenic activity or synaptic adhesion (McLoughlin et al., 1999).  
 Cell surface receptor 
The structure and the localization of full length APP at cell surface suggest that it could act as cell 
surface receptor (Kang et al., 1987). Moreover, it has been proposed that interaction of APP with 
other proteins could trigger signal transduction cascade similarly to Notch who share the same 
kind of processing by γ secretase (Hartmann et al., 2001). APP is known to interact with several 
proteins at cell surface like Aβ (Lorenzo et al., 2000), F-spondin (Ho and Sudhof, 2004), Nogo-66 
reducing amyloid plaques deposition (Park and Strittmatter, 2007), netrin-1 (Lourenco et al., 
2009). This could have an effect in the further processing of APP and modulate its cleavage (Zhang 
et al., 2012) 
Another study of Nikolaev shows that APP amino-terminal domain binds Death receptor 6 (DR6) 
triggering a self-destruction program leading to axonal degeneration. Activation of Death receptor 
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occurs during development and in case of trophic deprivation inducing beta cleavage of APP, 
leading to the degeneration of cell body (Nikolaev et al., 2009).  
Cholesterol metabolism  
Knowing that a polymorphic forms of apolipoprotein E is the more important genetic factor in AD  
and that APOE proteins are important cholesterol transporters in the brain, the relationship 
between AD progression and cholesterol metabolism has been widely studied (Shepardson et al., 
2011a, b). Indeed, cholesterol has been shown to stimulate the cleavage of APP 
into amyloid peptides by modulating secretase activity (Runz et al., 2002), and Aβ is also able to 
regulate lipid homeostasis (Grimm et al., 2007). In addition, a recent study published in our 
laboratory shows that APP can interact with SREBP (Sterol Regulatory Element-Binding Protein) a 
transcription factor that regulates transcription of genes involved in the control of cholesterol 
turnover which is important for synaptic activity (Pierrot et al., 2013). 
Soluble alpha APP 
Neurogenesis and neurite outgrowth 
Neurogenesis, the process by which new neurons are generated, occurs mainly during pre-natal 
development even if the adult brain is also able to produce new neurons from neuronal stem cells 
(NSC). Some clues indicate that sαAPP stimulates proliferation of NSC but also of different cell 
types (fibroblasts, epidermal, thyroid, ..) maybe explaining its ubiquitous functions (Baratchi et al., 
2012). The binding of sαAPPs  to  extracellular receptors could have a positive effect on neurite 
outgrowth in mouse neurons (Small et al., 1994).  
Learning and memory 
In addition to its neurotrophic properties, sαAPPs  regulates hippocampal NMDA receptor 
function, long-term potentiation and spatial memory (Taylor et al., 2008). Roch et al. have shown 
that sαAPP has positive effects on memory retention and consolidation (Ishida et al., 1997). 
Further evidences for a function of sα APP on memory formation was provided by Meziane et al 
who showed that intracerebroventricular injection of sαAPP restored learning deficits in amnesic 
mice. In this work, amnesia was induced by administrating the scopolamine, an anticholinergic 
drug inhibiting the binding of acetylcholine to muscarinic receptors and the subsequent 
neurotransmission (Meziane et al., 1998).  
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Neuroprotection 
Constitutive expression of sαAPP has a neuroprotective effect against several types of 
neurotoxicity (Mattson et al., 1993), including glutamate-mediated excitotoxicity or oxidative 
stress linked to Aβ production. sαAPP is also able to protect hippocampal neurons against ischemic 
injury (Smith-Swintosky et al., 1994).     
sαAPP is involved in many other cellular processes in the brain. This list is not exhaustive and gives 
only the key roles of this metabolite but sαAPP is also involved in other mechanisms as metal 
homeostasis, inflammation, heterodimerization ….For a complete review on APP fragments 
function see Chasseigneaux et al. (Chasseigneaux and Allinquant, 2012)  
Soluble beta APP  
Apart from 17 amino acids, sβAPP shares the same sequence than sαAPP. However, sβAPP lacks 
neuroprotective, and memory enhancer functions of sαAPP (Furukawa et al., 1996a; Furukawa et 
al., 1996b), and does not rescue cell death induced by a proteasome inhibitor epoxomicin 
(Copanaki et al., 2010). Moreover, knockin sβAPP in APLP2 null background fails to rescue the 
nerve sprouting and the neuromuscular junction phenotype (Li et al., 2010), as well as the 
perinatal lethality of APP/APLP2 KO mice (Weyer et al., 2014). The hypothesis of neuronal cell 
death induction by sβAPP or by a  cleaved fragments trough activation of caspase 6 has been 
mentioned (Nikolaev et al., 2009) but is still debated as sβAPP has been showed to be highly stable 
in vivo, and do not undergo further cleavage (Li et al., 2010). Yet, sβAPP contains the same 
sequence of sαAPP necessary to promote neurite outgrowth, and has been showed to increase 
axonal outgrowth (Chasseigneaux et al., 2011). Moreover, sβAPP has also been reported as an 
inductor of neuronal embryonic stem cells, in a more efficient way that sαAPP (Freude et al., 
2011). 
Amyloid β  peptide  
The inherent toxicity of Aβ in Alzheimer’s disease has stimulated the search for a potential 
function of Aβ. Monomers of Aβ are involved in many events in the brain since development to 
maturity. Monomeric Aβ at physiologic concentrations is involved in neurodifferentiation (Chen 
and Dong, 2009), and has neuroprotective and neurotrophic effects (Giuffrida et al., 2009; Yankner 
et al., 1990). Analysis of hippocampal slices points out that synaptic activity generates the 
secretion of Aβ that can further lower the synaptic transmission in neurons by negative feedback 
  Introduction 
27 
 
loop (Kamenetz et al., 2003). In vivo, low Aβ concentration modulates synaptic plasticity and 
memory by increasing long term potentiation (LTP) (Morley et al., 2010; Puzzo et al., 2008). Aβ 
generation is also associated to neurotoxicity, synaptic dysfunction, cognitive decline and finally 
amyloid deposition. Association of Aβ monomers into soluble oligomers can be due to the 
excessive concentration of this peptide (Selkoe, 1998) or disequilibrium in the ration between the 
2 major species Aβ 40 and 42 (Borchelt et al., 1996). Receptor-mediated uptake of Aβ oligomers 
(Bi et al., 2002; Wang et al., 2000) or interaction of Aβ with Prion protein could mediate 
neurotoxicity leading to memory  deficits (Laurén et al., 2009).  
APP Intracellular Domain (AICD) 
AICD is a short intracellular domain generated preferentially during amyloidogenic pathway 
following α and β cleavages of APP (Belyaev et al., 2010). Its size can vary from 50 to 59 residues 
depending on the γ cleavage site. AICD has been show to interact with several proteins through its 
YENPTY domain, and contains 3 phosphorylation sites that allow its phosphorylation by kinases 
such as PKC, GSK3β and Cdk5 (Schettini et al., 2010). Similarities between AICD and the 
intracellular domain of Notch (NICD), a well-established transcription factor, suggest that AICD 
could act as a transcriptional regulator.  
Therefore, a huge effort has been made in the last decades to identify target genes of AICD. Till 
now, the list of genes regulated by AICD include KAI (Baek et al., 2002), GSK3β (Kim et al., 2003), 
Neprilysin (Belyaev et al., 2009; Pardossi-Piquard et al., 2005), p53 (Checler et al., 2010), 
transthyretin & Klotho (Li et al., 2010) , AQP1 (Huysseune et al., 2009), APP (von Rotz et al., 2004), 
and a cluster of genes involved in cytoskeletal organization (Müller et al., 2007). However, the 
question of the ability of AICD to regulate expression of target genes remains a matter of debate. 
Indeed, several groups have difficulties to reproduce results or to provide evidence of a DNA 
binding activity of AICD (Aydin et al., 2011; Chen and Selkoe, 2007; Hébert et al., 2006; Waldron et 
al., 2008; Yang et al., 2006) . 
The first results showing transcriptional activity of AICD was given by Cao and Sudhof in 2001. 
They discovered  a transcriptionally active complex encompassing AICD, the histone 
acetyltransferase Tip60 and the adaptor protein Fe65 (Cao and Sudhof, 2001). Since then, a lot of 
hypothesis on how AICD could translocate to the nucleus to regulate gene transcription have 
emerged. It is important to note that AICD can interact with many binding proteins (as the Janus 
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kinase interacting protein-1 (JIP-1)), transcription factors or proteins involved in trafficking, to 
activate or suppress its transactivation, and that AICD transfer in the nucleus can be Fe65 
dependent or independent (Biederer et al., 2002; Cao and Sudhof, 2004; Kim et al., 2003; Nakaya 
and Suzuki, 2006; Scheinfeld et al., 2003). All AICD produced in the cell is not transcriptionnaly 
active, as its seems that the cleavage of AICD by the non amyloidogenic pathway occuring at 
plasma membrane would lead to its degradation, while the amyloidogenic pathway occurring in 
endosome releases an AICD that can be stabilized to translocate into the nucleus (Grimm et al., 
2013). An important functional link in those regulations of transcription by AICD could be the 
MED12 unit which forms part of Mediator, a multiprotein complex with a RNA polymerase II 
transcriptional activity that has been show to regulate both neprilysin and AQP1 expression. Xu et 
al. propose a model in which AICD bound to a promoter recruits Mediator through its MED12 
interface to stimulate transcription (Turner et al., 2003; Xu et al., 2011). A model of AICD 
translocation to the nucleus by several mechanisms leading to regulation of NEP expression is 
explained in the figure 6. 
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Focus on AICD as epigenetic partner  
Epigenetic modification linked to AICD presence on gene promoter has been widely studied by 
Turner’s group (Beckett et al., 2012; Belyaev et al., 2010; Belyaev et al., 2009; Kerridge et al., 2014; 
Turner et al., 2003). Together with Belayev and Nalivaeva, they focus their research on the ability 
of AICD to regulate gene transcription trough epigenetic mechanisms. The starting point of their 
research was the identification of an association between AICD and the neprilysin gene promoter 
by chromatin immunoprecipitation (ChIP) experiments. Neprilsysin (NEP), is an Aβ degrading 
metalloprotease and its expression was previously identified by Pardossi-Picard to be regulated by 
APP (Pardossi-Piquard et al., 2005). By comparing two different neuroblastomes, they showed that 
AICD binds to the NEP promoter in neuronal cells expressing high levels of NEP while in low NEP 
Figure 6. Model of potential mechanism of AICD-mediated gene regulation. While AICD 
produced at cell surface by the non-amyloidogenic pathway is rapidly degraded, amyloidogenic 
pathway that takes place in endosome produce the AICD that can be stabilized by binding to
the adaptor Fe65 or JIP-1 and translocate to the nucleus. Alternatively, Tip60 associated with 
Fe65 and AICD can bind to the MED12 proteins which will links these complexes to the RNA 
polymerase transcription apparatus (adapted from Grimm)(Grimm et al., 2013). 
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expressing cells, the NEP promoter is repressed by histone deacetylases (HDACs). Moreover, the 
transcription of NEP gene was sensitive to an HDAC inhibitor only in cell lines that show 
enrichment of HDAC1 on gene promoter, while promoter enriched in AICD show a higher level of 
histone acetylated (H4K8,16). 
In our laboratory, the work of S. Huysseune on APP KO cell lines demonstrated an AICD dependent 
control of aquaporin1 (AQP1) gene transcription in an epigenetic manner. In mouse embryonic 
fibroblast (MEF) cells, she demonstrated that AICD regulates expression of AQP1, neither by 
modifying the transcriptional activity of AQP1 gene promoter nor by stabilization of its mRNA. The 
sensitivity of AQP1 expression to an HDAC inhibitor and association of HDAC activity with AICD 
allowed to conclude that AICD is involved in the epigenetic control of AQP1 gene expression. This 
regulation by AICD and HDACs could occur indirectly by the epigenetic regulation of a gene 
repressor, that will in a second time regulate AQP1 expression (Huysseune et al., 2009). 
H. APP knockout models 
Diverse simple or combined mutants for APP family members have been generated and 
characterized:  
• Mice simple mutant for APP have been produced by inserting neomycin cassette in exon 2 
of APP gene or by CRE recombinase technology (Li et al., 1996; Muller et al., 1994; Zheng 
et al., 1995). They are viable and fertile but show a smaller size along with a reduce brain 
and body weight independently of their genetic background (Magara et al., 1999; Zheng et 
al., 1995). They have been largely studied at morphological and behavioral levels, and 
were used in this work to understand the function of APP. APLP1-KO mice show really 
minor phenotype of somatic growth deficit (Heber et al., 2000) where APLP2-KO mice 
studies reveal absolutely no abnormalities to date (von Koch et al., 1997). 
• Double mutant APLP2/APLP1 and APLP2/APPKO die shortly after birth while APLP1/APP 
DKO are viable, fertile and without defects (Heber et al., 2000).  
• Triple KO mice lacking all APP family members die shortly after birth and 80% of them 
have cranial abnormalities (Herms et al., 2004) 
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Given that several types of APP mutants die perinatally, the involvement of APP and homologs 
into biochemical pathways appears to be essential to cell metabolism (von Koch et al., 1997; 
Zheng et al., 1995).  
From a histological point of view, APP KO mice show an increase incidence of agenesis in corpus 
callosum (Muller et al., 1994),reduce size of forebrain commissure especially of hippocampus 
(Magara et al., 1999) and a reactive gliosis mainly in cortex and hippocampus accompanied by a 
loss of reactivity of synaptic markers in these regions (Dawson et al., 1999; Zheng et al., 1995). 
In behavioral tests, APP KO mice show severe impairments in spatial learning and exploratory 
behavior (Muller et al., 1994), and altered circadian activity (Ring et al., 2007). APP KO mice also 
exhibit deficits in neuromuscular junctions (NMJ) explaining the decreased locomotors activity and 
the impaired grip strength phenotype (Zheng et al., 1995).  Wang and coworkers identified 
APP/APLP2 as key regulators of structure and function of developing neuromuscular synapses, and 
in the synapse patterning (Wang et al., 2005). The effect of APP on NMJ could be due to the 
specific regulation of GDNF expression by APP (Stanga, to be published).   
In Morris water maze (MWM), APP KO mice show impairments in learning and spatial memory as 
task acquisition and spatial representation, are less active in a novel environment but don’t have 
reduced visual, swimming and motor skills (Dawson et al., 1999; Phinney et al., 1999; Ring et al., 
2007). Essential function of APP in synaptic function was supported by Dawson et al. who show 
age dependent deficit in cognitive function and impairment in LTP (Dawson et al., 1999). Later, 
Seabrook et al. showed deficit in LTP formation in CA1 region of APP KO mice at 8–12 months of 
age. It seems that APP dependent impairments of synaptic plasticity are not due to a gross loss of 
neurons or synapse in the brain but more likely to a failing in neuronal network settlement, maybe 
due to defect in Ca2+ handling or GABAergic transmission (Phinney et al., 1999; Seabrook et al., 
1999; Yang et al., 2005). 
Finally, APP KO animals are hypersensitive to seizures induced by kainate (Steinbach et al., 1998), 
and from our observations, start epileptic seizures without any induction processes. This behavior 
could be related to the role of APP in the control of neuronal excitability.  
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Limitation of the model and role of APLP proteins 
APP KO mice were used in this work in order to evaluate the role of APP on gene transcription. 
However, as every model where a protein is knocked down or overexpressed, we faced several 
limitations (Picciotto and Wickman, 1998). Here, the major point is the compensatory effect of 
APP like protein family members. Indeed, the phenotype of APP KO mice is very discrete, while 
lethality is observed in APLP2/APP KO and in APLP1/APLP2 KO mice (Heber et al., 2000). This 
highlights the redundant functions of these proteins. Except their inability to produce Aβ, APLP 
proteins share high homology with APP, as conserved binding domains and are also able to release 
an intracellular domain (ICD). As APP, APLPs play important roles in neuronal differentiation and 
migration (Shariati et al., 2013), in dendritic architecture (Weyer et al., 2014), in synapse 
formation and function (Korte et al., 2012), in neuromuscular transmission (Klevanski et al., 2014) 
and in spatial learning and synaptic plasticity. APLPs could also control transcription of several 
genes involved in memory formation (Weyer et al., 2011). However, it seems that APP and APLP2, 
share more features than APLP1, which localization and nuclear signaling by ICD differ from its 
homologous (Gersbacher et al., 2013; Kaden et al., 2009). 
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II. Epigenetics	in	the	nervous	system:	from	
memory	formation	to	Alzheimer’s	disease.	
A. Brief	introduction	on	epigenetics	
Changing the way our genes are expressed without changing the DNA sequence in order to give a 
diverse readout of genome is the basis of epigenetics. Indeed, every cell of each organism shares 
exactly the same genetic information and thereby need a way to differentially regulate gene 
expression to adjust to the environment, allow cell differentiation or inactivate unwanted portion 
of the genome as chromosome X.  The control of gene expression can occur at two levels: the 
activation of gene transcription by transcription factors or the reversion of the switch “OFF” 
positions of gene by epigenetic mechanisms. There are three kinds of epigenetic silencing: 
modification of DNA or  chromatin, or RNA-associated silencing  (Egger et al., 2004). 
The epigenome  
In the nucleus, the DNA fibers (that can reach 2m length) are packed tightly into chromosomes, 
the highest structure of DNA organization. Inside the chromosome, DNA is wrapped around 
globular proteins to form the chromatin in a “beads on a string” arrangement (Figure7A). The basic 
unit of the chromatin is the nucleosome, a structure composed of an octamer of histones 
surrounded by approximately 146 base pairs of DNA (Figure7B). Core histones are four in number 
(H2A, H2B, H3 and H4), associate by pairs with tails coming out of the nucleosome which undergo 
modifications to adapt the accessibility of DNA to transcription factors. Histone H1 is a linker 
histone connecting the DNA in and out of the nucleosome.   
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DNA Methylation 
Adding methyl groups to DNA elicits gene repression by modifying chromatin structure.  DNA is 
methylated on cytosine to form 5-methylcytosine (5mC) considered as the fifth paired base as it 
have specific role and influence many biological processes  as transcriptional regulation, genome 
imprinting, and maintenance of genomic stability. DNA methylation occurs specifically on cytosine 
residues located next to guanine, directly connected by a phosphodiester bond (CpG). In the 
genome, CpG are usually methylated and largely underrepresented due to the trend of 
methylated residues to spontaneously deaminate to form Thymidine. However, regions called 
“CpG Island” of 300 to 3000 pairs of base are unusually rich in C and G nucleotides (60% while 5% 
in general).  CpG Islands are often located on the regulatory regions of genes, and trend to be 
largely unmethylated at housekeeping gene promoters (Deaton and Bird, 2011). The enzymes 
catalyzing the transfer of methyl group from SAM (S-adenosyl-L-methionine) to 5-methyl cytosine 
are DNA methyl transferase (Dnmt). In eukaryotes, Dnmt 1 is responsible for the maintenance 
methylation, maintaining the methylation pattern once established during embryogenesis while 
Dnmt3a and Dnmt3b show de novo methylation activity (Figure 8). DNA methylation prevents 
gene transcription by steric interaction making DNA less accessible to transcription factors, and 
through the action of complexes containing MBD proteins (methyl CpG binding domain). Family of 
Figure 7 : A. DNA is packed into chromatin in a “beads on a string” structure. B. Zoom in the nucleosome 
containing octamers of histones (H2A,H2B, H3,H4) and the histone H1 as linker. (Abcam) 
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MBD proteins contains members (MBD1,2,3,4 and MeCp2)  capable to reads and interpret 
methylation marks on DNA,  and to recruit co-repressor complex as HDACs and chromatin 
remodeling factors in order repress the transcription (Sansom et al., 2007) 
 
 
 
 
 
 
 
 
Till last decade, the enzymatic reaction underlying DNA demethylation was still missing.  Recent 
discoveries show that DNA demethylation is not occurring by a direct enzymatic removal of methyl 
group but by two indirect mechanisms: The first mechanisms is passive, and occurs in absence of 
functional DNA methylation machinery (reduction or absence of maintenance methyltransferase 
DNMT1 activity) resulting in passive dilution (PD) of the methyl mark during successive rounds of 
replication. The second mechanism is active, and refers to an enzymatic process that removes or 
modifies the methylgroup from 5-methylcytosine (5mc). It is schematized in figure 9, and is 
composed by a two-step enzymatic reaction with 5-hydroxymethyl cytosine (5hmc) acting as a key 
intermediate in the reaction of DNA demethylation. As 5mc, 5hmc can also undergo passive 
dilution. Nevertheless, removal of oxidized methyl group can occur in an active way. During this 
process, 5mc is actively converted 5hmC in a reaction catalyzed by the ten-eleven translocation 
(TET) family of enzymes. 5hmC can further be oxidized by TET enzymes in 5-formylcytosine (5fC), 
and 5-carboxylcytosine (5caC) (Pastor et al., 2013; Tsagaratou and Rao, 2013). 5fC and 5caC are 
Figure 8 : DNA can be methylated in the CpG island regions, conferring a repressing state to the gene. 
Methylation is catalyzed by DNMT de novo (dn DNMT or DNMT3) or maintenance (mDNMT or DNMT1), 
(Day and Sweatt, 2010). 
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recognized and excised by a thymine DNA glycosylase (TDG) into abasic sites as part as the 
subsequently DNA repair pathway that ultimately replace them through to generate unmethylated 
cytosine (Kohli and Zhang, 2013). 5hmC has also been suggested to be directly demethylated by 
enzymes that normally target and remove unmodified cytosine (Bhutani et al., 2011; Li et al., 
2013). To be noted, modified cytosines can also act as epigenetic marks that can recruit 
chromatin-bound regulatory proteins. 
 
 
 
Histone modifications 
Histones can undergo a large range of covalent modifications on one of the 60 residues located on 
their amino-terminal tails (Kouzarides, 2007).   
Acetylation is maybe the most studied histone modification; occurring only on lysines, it is 
systematically associated with opening status of chromatin. The level of acetylation of a gene 
promoter or a regulatory region of a gene will define the opening status of chromatin. A low level 
of histone acetylation (deacetylation or hypoacetylation) will be associated to heterochromatin, 
lacking transcriptional activity, while hyperacetylation will be associated to euchromatin, a relaxed 
Figure 9  Active DNA demethylation 
pathway.  
5mC base obtained by the action of DNA 
methyltransferase (DNMT) enzymes, can
be hydroxylated by the ten-eleven 
translocation (TET) family of enzymes to 
form 5-hydroxymethylcytosine (5-hmC) or 
further oxidized to 5-formylcytosine (5fC) 
and 5-carboxylcytosine (5caC). Active 
modification (AM) followed by passive 
dilution (PD) of 5hmc regenerate 
unmodified cytosine. In the pathway of 
active modification, followed by active 
restoration (AR), 5fC or 5caC is excised by 
TDG generating an abasic site as part of the 
base excision repair (BER) process that 
regenerates unmodified cytosine, 
demethylating the DNA (Kohli and Zhang, 
2013). 
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form of chromatin allowing fixation of transcription factors (MacDonald and Roskams, 2009).    
Adding acetyl group to lysines will confer a negative charge neutralizing the positive charge of 
lysines and diminishing attraction with DNA negatively charged. However, the main effect on gene 
transcription is due to the fact that acetylated lysines are recognized by proteins containing 
bromodomain modifying the status of chromatin. Indeed, bromodomains are structural modules 
present in many diverse chromatin associated protein and histone acetyltransferases necessary in 
their targeting to specific sites. Due to their acetyl-lysine binding site, they are able to detect and 
bind acetylated lysines on proteins (Zeng and Zhou, 2002). Human bromodomains proteins are 
classified in 8 subfamilies containing among other histone acetyltransferase like GCN5, PCAF 
(CBP/P300 associated factor) or CREBBP (CREB Binding Protein), ATP-dependent chromatin 
remodeling complex, transcriptional coactivators or methyltransferases (Filippakopoulos and 
Knapp, 2012; Marmorstein and Berger, 2001; Sanchez and Zhou, 2009)  
In the histone code, methylation of histones is a more complex modification as two residues 
(lysines or arginines) can be potentially mono-, di-, or trimethylated. Moreover, methylation can 
lead to a repressive or activating effect (table 1). All those modifications together with 
phosphorylation, ubiquitylation, sumoylation are not static but in a constant dynamic to reshape 
chromatin in response to cell stimuli (Akbarian and Huang, 2009).   
Table 1 : Overview of transcriptional state associated to specific lysines modifications on histones . 
(Adapted from (Akbarian and Huang, 2009)  
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Figure 10 summarizes epigenetic modifications of DNA methylation and histone acetylation.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10 : Epigenetic regulation of gene expression.  
A) The structure of the nucleosome includes DNA wrapped around a histone proteins, from which emerge 
histone tails that can be modified by post-translational mechanisms. B) Transcriptional activation requires the 
unwrapping of DNA from the histone core to promote binding of RNA polymerase. C) Adding methylgroup to the 
DNA represses transcription and is mediated by DNA methyltransferase. D) Methylated DNA attracts methyl-
binding proteins which further condense the structure of the nucleosome and prevent transcription. E) Histone 
acetylation involves the addition of an acetyl  group on specific  lysines located to the histone tails and is 
mediated by histone acetyltransferase (HAT). Removal of the acetyl group is mediated by histone deacetlylase 
(HDAC) and leads to a more compact and less accessible nucleosome, less transcriptionally active. F) Increasing 
levels of HDAC inhibitors can block the actions of HDAC and thus promote greater access to the DNA (Fagiolini et 
al., 2009). 
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Histone modifying enzymes  
The equilibrium between acetylation and deacetylation is regulated by Histone acetyltransferase 
(HAT) and histone deacetylase (HDAC).   
HDACs 
Mammalian HDACs are divided into three different classes based on yeast factor homology. Class I 
HDACs are homologous to yRPD3, in majority nuclear and their expression is ubiquitous. They 
include HDAC1, HDAC2, HDAC3, HDAC8 and HDAC11. Class II HDACs can transit from the nucleus 
to the cytoplasm, are expressed in a restricted number of organs as heart, skeletal muscle and 
brain. They are homologous to yRPD3 and yHDA1 and include HDAC4, -5, -7 and -9 in the class IIa, 
and -6 and -10 in the class IIb.  Histones of class I and II are referred as “classical” HDACs and are 
sensitive to the HDAC inhibitor trichostatin A (TSA). The last class of HDAC also called sirtuins 
doesn’t show homology with class I and II but is homologous to ySIR2. Sirtuins are not sensitive to 
TSA and require NAD+ as cofactor (Verdin et al., 2003). HDAC activity is not specific to histones 
proteins as HDAC are able to deacetylate many other substrates like tubulin for HDAC6. HDACs 
take part to cell fate from differentiation to apoptosis, and are also implicated in oncogenic events 
(Sengupta and Seto, 2004). HDACs functional activity is determined by the binding to cofactors 
that give the DNA-binding activity, and by their interaction with protein composing large multi-
subunit complex. For example HDAC1 and HDAC2 exist in mSin3a, NuRD or CoREST multi-protein 
complex (Grozinger and Schreiber, 2002).  
Histone acetyl transferases 
Histone acetyl transferases are enzymes catalyzing the transfer of an acetyl group from a cofactor 
(acetyl-CoA) to lysine. HAT may be located in both the nucleus and the cytosol, and acetylate other 
substrate as transcription factors influencing the biological function of the modified proteins. HATs 
are classified into 5 families:  GNAT, MYST, CBP (CREB Binding Protein) /p300, SRC, others (TAF II). 
HAT from the same family share a large homology, but lack any sequence similarity between 
families. Contrariwise to HDAC that don’t show any substrate specificity, HAT activity is specific to 
some residues (table2).  
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Table 2. Histone acetyltransferase family and histones residues modification associated to each histone 
acetyltransferase (adapted from Marks (Marks et al., 2001)) 
 
 
 
 
 
 
 
Since 2007, a new nomenclature for histone modifying enzymes (HME)  has been settled due to 
the rapid rate of discovery of new enzymes and the need to give consistent name between 
species. For example, lysine acetyltransferase have been named KAT while lysine 
methyltransferase became KMTs (Allis et al., 2007). Even if this new nomenclature is really needed 
to avoid confusion, I take the decision in this work to use the usual denomination of these 
enzymes and to describe only the histone modifying enzymes related to Alzheimer’s disease and 
APP metabolism that are CBP/P300 and Tip60. 
CBP/P300 
CBP and p300, also named KAT3A, KAT3B are two highly homologous proteins sharing several 
conserved regions including functional domains or binding site for transcription factors (figure11). 
More than homology, studies have confirmed that CBP and p300 share overlapping functions 
leading to a unique denomination.  CBP/p300 complex was firstly identified as P-CREB binding 
proteins (CBP) and factors interacting with the adenovirus E1A protein (p300) (Chrivia et al., 1993; 
Eckner et al., 1994). Since then CBP/p300 has been show to interact with many other proteins 
mostly through their bromodomain. Histone acetyltransferase activity of CBP/p300 gives them the 
ability to remodulate chromatin and make them global regulators of transcription (Marmorstein, 
2001). CBP/p300 also interacts with the transcriptional machinery such as RNA PolII and 
transcription factors to induce a transcriptional synergy. CBP/p300 is able to integrate a lot of 
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signaling cascades and mediates the transcriptional response in many cellular events. 
Transcriptional regulation by CBP/p300 can occur via a bridge formed between transcription 
factors and basal machinery, by scaffolding other proteins to form larger co-activator complex or 
directly through their histone acetyltransferase activity.  
 
 
 
 
 
 
 
 
 
 
 
Tip 60 
Tip60, also named KAT5, belongs to the MYST family and was first discovered as HIV-1 TAT-
interactive protein (Kamine et al., 1996). Tip60 is involved in many events: cell signaling, DNA 
damage repair, cell cycle and apoptosis (Clarke et al., 1999; Tang et al., 2006).   
In drosophila, catalytic HAT domain of dTip60 is critical for the acetylation of endogenous histone 
H4 ,is  required for the transcriptional regulation of genes involved in neuronal function (Lorbeck 
et al., 2011) and is important for the regulation of synaptic plasticity via the control of synaptic 
bouton expansion (Sarthi and Elefant, 2011).  
Figure 11 : CBP/P300 share large homology and bind numerous proteins through different domains (Adapted 
from Chan et al.)(Chan and La Thangue, 2001) 
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Stability of epigenetics in neurons?  
In a strict definition, epigenetic refers to mitotically or meiotically heritable changes in gene 
transcription that are unrelated to variation in DNA sequence. Indeed, the change of phenotype 
induced by epigenetic mechanisms is not written in the DNA but must pass from a generation to 
another, reflecting the environmental changes that occur in the lifetime of an individual. However, 
concerning the epigenetic regulation of neuronal gene transcription, this definition needs an 
adaptation at two levels. (1) Neurons are not mitotic, so the replication-dependent mechanism of 
propagation of DNA methylation is excluded. (2) Some histone modifications like acetylation are 
transient and readily reversible. Thus, even if the notion of heritability is lost in neurons, the 
dynamics of epigenetics landscape still makes it adjustable to the environment via both dynamic 
modification as histone modifications and more long lasting one as DNA methylation (Kouzarides, 
2007; Meaney and Ferguson-Smith, 2010).   
B. Regulation of IEGs upon memory formation 
Memory formation is a really dynamic and complex mechanism involving distinct neural systems. 
The formation of different kinds of memories takes time to emerge and persist, and requires many 
cellular changes. In the brain, separate neural structures are responsible for different forms of 
learning (Nadel and Hardt, 2011). Here, I will shortly introduce the main regions important for 
memory formation that are further studied in my thesis work: hippocampus and prefrontal cortex. 
Hippocampus 
Hippocampus is a region of the brain from the limbic system, dedicated to acquisition and 
encoding of new memories. This region is specialized in the long-term memory formation and in 
the spatial navigation. First evidences about the function of hippocampus result from an 
observation from William Scoville and Brenda Milner.  They studied the impact of a surgical 
removal of the hippocampus region of an epileptic patient (named H.M.) and discovered that the 
procedure was followed by incapacity of the patient to create new memories, without any effect 
on ancient memories reminding. They conclude that hippocampus was necessary for the 
formation of memory to recent events (Scoville and Milner, 2000). Since then, hippocampus has 
been described as an essential actor for the rapid formation of new memories and for the 
prolonged process of consolidating newly acquired memories (Preston and Eichenbaum, 2013). 
Memory mediated by hippocampus concerned primarily episodic memory, conscious recollection 
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of detailed and autobiographic events in human, and the storage and the recovery of contextual 
specific memories in animals (Nadel and Moscovitch, 1997; Winocur et al., 2010). 
Prefrontal cortex  
Prefrontal cortex (PFC) is usually depicted as the main region involved in the decision making and 
in memory formation, together with the hippocampus. Over the many functionally distinct areas 
composing the prefrontal cortex, it is important to note that the medial prefrontal cortex (mPFC) 
appears to be particularly involved in memory retrieval and consolidation (Preston and 
Eichenbaum, 2013). 
 Memories associated with the prefrontal cortex diverge from the hippocampus , are of two types 
: the “remote” memory , i.e. remembrance of items learned several weeks to months earlier, but 
also a more “recent” form of memory, of items learned 1-2 days before (Euston et al., 2012). 
Experiments on rats submitted to task rewarding have also enable to determine a role of PFC in 
the short term memory formation. Indeed Tronel and Sara showed that interfering with the cortex 
(by blocking NMDA receptors) induce amnesia, and the subsequent recall of certain specific tasks, 
pointing out the function of PFC in the consolidation of memory (Tronel and Sara, 2003). 
The role of PFC in the long term memory has been demonstrated in a large range of events as 
Morris water Maze, contextual fear conditioning or conditioned test aversion, as well as in the 
case of drug dependence. All those studies established the role of PFC in the reinstatement, the 
consolidation, the storage and retrieval of remote memories. However, even if the greatest role of 
PFC remains remote memorization others studies have demonstrated the need of PFC in the 
remembrance of short term memories, especially in the working memories events (Uylings et al., 
2003) . 
Connection between hippocampus and prefrontal cortex are unidirectional and particularly strong. 
Several roles have been attributed to the hippocampal input in the cortex: providing a context, 
enabling associative learning and also supporting rapid learning (Wise and Murray, 2000). 
Moreover, interactions between hippocampus and the medial prefrontal cortex are necessary to 
the organization, consolidation, and flexible retrieval of memories (Preston and Eichenbaum, 
2013).Other studies have also shown that communication between PFC and hippocampus was 
necessary for short term paradigm including several behavioral tests as spatial maze (Wang and 
Cai, 2006).   
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Molecular basis of memory formation  
The memory is the process by which the knowledge is encoded and stored to be retrieved later. 
There are two types of memory; the explicit or declarative one is associated with knowledge of 
facts, while the implicit or non-declarative memory is related to task performance. At cellular 
level, the mnemonics capacity depends on the quality of the neuronal network and in the synapse 
connectivity (Okuno, 2011). The ability of a network to acquire new information and to give the 
adaptive response to stimuli depends on the synaptic plasticity, i.e. the ability 
of synapses to strengthen or weaken over time, in response to increases or decreases in their 
activity. Synaptic plasticity can be electrophysiologicaly measured trough long term potentiation 
evaluation: LTP (Kandel et al., 2014).   
At cellular level, the biochemical process of memory formation could be synthesized in four steps:  
1. Activation of NMDA (N-methyl-D-aspartate) and AMPA (α-amino-3-hydroxy-5-methyl-4-
isoxazolepropionic acid) receptors by the presynaptic glutamate, creating a post-synaptic 
membrane depolarization and calcium entry.  Activation of protein G-coupled receptor 
leading to an increase in intracellular cAMP concentration or activation of receptor 
tyrosine kinase by growth factor can contribute to the cascade of events leading to 
memory formation. 
2. Calcium influx activates Ca
2+
/Calmodulin dependent kinase (CaMKII & CaMKIV), the 
ribosomal S6 kinase (RSK) and the mitogen- and stress-activated protein kinase (MSK). 
Calcium mediates also the ERK/MAPK pathway leading to the activation of calcium-
responsive DNA regulatory element as the serum response element (SRE). 
3. Translocation of these kinases to the nucleus where they phosphorylate the cAMP 
response element-binding protein (CREB) transcription factor at Serine 133 leading to CBP 
recruitment.  
4. Binding of p-CREB to CRE response element leading to epigenetic modification of histones 
surrounding genes promoters and subsequent production of mRNA of proteins involved in 
synaptic plasticity.  
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Participation of CREB in memory formation is due to the ability of this transcription factor to 
regulate gene coding for proteins necessary for the structural and functional changes needed 
in neurons to conserve a memory trace of the new experience (figure 12). CREB can acts 
directly by regulating the expression of synaptic regulators (transcription factors i.e.) and 
effectors like the Bdnf (Takeuchi et al., 2014). Indeed, CREB target genes encode a large 
variety of proteins as neurotransmitters, adhesion and signaling molecules involved in 
neuronal plasticity, survival and differentiation. Among them, CREB regulates secondary 
transcription factors as Fos and Egr-1, each controlling specific genes but having all as 
consequences of their activation a structural changes in neurons inducing synapse remodeling. 
CREB regulates also the neuronal intrinsic excitability through transcriptional regulation of 
protein kinases and phosphatases, sodium channel subunits or by decreasing the expression of 
potassium channels through induction of transcriptional repressor as miRNAs.  So CREB 
activation is followed by a synaptic remodeling through the creation of new dendritic spines, 
enlargement and pruning of existing spines but also by the modulation of Na+ and K+ currents 
regulating intrinsic excitability.  (Barco and Marie, 2011; Benito and Barco, 2010; Benito et al., 
2011). This process should also involve the microtubule-dependent transport of new mRNA to 
synaptic regions and local regulation of translation (Tully et al., 2003).  
Figure 12 : Biomolecular basis of memory formation. Activation of NMDA receptors by glutamate 
induce Ca2+ efflux in postsynaptic neurons, inducing several signaling pathway, leading in a first step 
in the  immediate early genes transcription by CREB dependent mechanisms, and further in protein 
synthesis that will induce long lasting changes in synaptic strength (adapted from (Tully et al., 2003) 
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CREB & CBP 
CREB is a transcription factor that binds CRE site, firstly identified in somatostatin gene promoter 
(Montminy and Bilezikjian, 1987). CREB is closely related to two other transcription factors from 
the same family: CREM (cAMP response element modulator) and ATF-1 (activating transcription 
factor 1). CREB mediates both cAMP and calcium dependent transcription in the nucleus, and is 
regulated by phosphorylation on the critical residue Serine 133. The specific mutation of this site 
was shown to inhibit the CREB-dependent gene activation (Gonzalez and Montminy, 1989). The 
production of antisera able to recognize specifically the phosphorylated form of CREB, allow the 
detection of an increased phosphorylation leading to the subsequent CREB activation in response 
to physiological levels of neurotransmitters release in brain and neurons  (Ginty et al., 1993).  
Involvement of CREB in memory processes and in synaptic potentiation was largely studied. First 
studies of Aplysia californica lead to the identification of the cAMP-signaling pathway as a core 
component of the molecular switch that converts short- to long-term memory  (Brunelli et al., 
1976). This marine invertebrate was thoroughly studied in the team of Eric Kandel, to understand 
the mechanisms underlying synaptic plasticity due to its low number of large neurons easily 
identified, and its ability of learning several tasks (Dash and Moore, 1996; Hawkins et al., 2006; 
Kaang et al., 1993). Later, specific work on drosophila clearly established the role of CREB in 
memory formation and in memory-related synaptic plasticity (Yin et al., 1994). From there, the 
role of CREB in learning and memory events occurring in mammals has been shown in 
hippocampus and other brain structures (Balschun et al., 2003; Benito and Barco, 2010; 
Bourtchuladze et al., 1994).  However, even if  expression of constitutively active CREB in 
postsynaptic neurons of Shaffer collateral of hippocampus leads to a strong transcriptional 
activation that could facilitate the establishment of late LTP  (Barco et al., 2002) , chronic boosting 
of CREB expression is related to physiological and plasticity alterations in hippocampal circuits of 
behaving animals, and eventually to memory deficits(Gruart et al., 2012; Viosca et al., 2009). 
Serine 133 phosphorylation occurs via different kinases: PKA mediates more likely cAMP 
dependent phosphorylation while RSK6 and mitogen- and stress-activated protein kinase (MSK) 
mediate calcium dependent phosphorylation. This makes CREB able to bind the transcriptional 
coactivator CBP (CREB binding protein) (Lonze and Ginty, 2002). Intrinsic HAT activity of CBP is 
responsible for the increase of histone acetylation on target genes promoter and the consequent 
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expression of CREB target genes. Those epigenetic changes are also followed by the removal of 
several HDACs to gene promoter. Figure 13 describes the effect of synaptic activity on chromatin 
status. In resting state, gene promoter is surrounded by some transcriptional repressor complexes 
containing HDACs as HDAC1 and HDAC2 but also by methyl binding proteins like MeCP2. Synaptic 
activity or calcium entry after depolarization will induce the removal of these repressors, and the 
attraction of phosphorylated CREB along with CBP whose acetyltransferase activity will allow the 
acetylation of histone H3 and H4 at CRE site of the gene.  
 
 
 
Figure 13 : Epigenetic changes at CREB-dependent gene promoter. Gene repression by multiccomplex 
containing HDAC1 and HDAC2 is reversed in case of neuronal stimulation, by the recruitment of activating 
complex of CBP and CREB inducing histone acetylation and gene expression, adapted from (Riccio, 2010). 
 
C. Immediate early genes 
 
Immediate early genes (IEGs) are a family of genes that do not require protein synthesis to be 
transcribed. De novo production of IEGs transcripts is occurring rapidly and transiently after 
stimulation. They were firstly described in virology, where they referred to viral genes rapidly 
transcribed after infection of a host cells. Later, IEGS were studied in fibroblasts as the 
proliferative response to growth factors but the corresponding proteins  were finally described as 
much more complex proteins acting in structure, signaling or as transcription factors (Okuno, 
2011).  
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In the brain, neuronal IEGs (Table 3) are induced in response to synaptic transmission, via CREB or 
ERK pathway and are essential in the memory processes. Neuronal IEGs family includes among 
others, transcription factors (Egr-1, c-Fos), signaling proteins (rheb, cox-2) and synaptic 
modulators (arc, homer-1a).  
Table 3 : Neuronal activity-regulated IEGs ; adapted from (Okuno, 2011) 
 
 
Egr-1 
Early growth response protein 1 (also known as NGFI-A, Krox-24, Zif268, Tis8 or ZENK) is a member 
of zinc finger transcription factors family sharing large homology with Egr-2 and Egr-3.  Firstly 
discovered as a gene induced after treatment with mitogenic agent as TPA (and so called Tis8) (Lim 
et al., 1989), Egr-1 transcription has also been described to be sensitive to nerve growth factor 
(NGFI-A)(Milbrandt, 1987), to play a role on the post natal neurogenesis (Krox24) (Lemaire et al., 
1988) to act as a zinc finger transcription factor (Zif268) (Kang et al., 1987) or to be important for 
songbird learning giving the name ZENK to its avian homolog (Mello and Clayton, 1995).  
The murine Egr-1 gene is a 3,8kb DNA sequence and its promoter contains several highly 
conserved regulatory regions (Tur et al., 2010):  
- 5 serum response elements (SRE), of which only 2 are functional. SRE can be recognized 
by the Serum Response factor (SRF) making ternary complex with Elk1. SRF is induced 
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through activation of ERK, JNK and p38 via MAPK pathway, activated by many types of 
growth factors.  
- 2 CRE elements. CRE are binding sites for CREB transcription factor after its activation via 
calcium or cAMP pathway. CREB dependent activation of Egr-1 promoter is strongly 
induced by synaptic activity. CREB phosphorylation on serine 133 enables Egr-1 
transcription, while CREM binding to CREB forms a heterodimer inhibiting this activation. 
- 2 AP-1 elements (Activator protein 1): enable the binding of the fos-Jun complex to Egr-1 
promoter. Regulation of Egr-1 by c-Fos has been described in rat where treatment with c-
Fos antisense oligonucleotide reduces expression of Egr-1 in the caudate nucleus and 
cortex (Dragunow et al., 1994).  
- 3 GC box, allowing the binding of Egr family members and especially Egr-1 itself conferring 
an autoregulation property to Egr-1  (Beckmann and Wilce, 1997). Two SP1 (specificity 
protein 1) sites are overlapping the GC box. In many instance Egr-1 and SP1 play opposing 
roles, and it could result of the direct interaction for their overlapping binding sites.  
Due to de large expanse of Egr-1 promoter, a small part of it is described in figure 14 :  
 
Activation of Egr-1 
Egr-1 mRNA is constitutively synthetized in rat neocortex, olfactory and enthorinal cortex, 
amygdala, nucleus accubens, striatum, cerebellum and in the CA1 region of hippocampus 
(Schlingensiepen et al., 1991). The constitutive Egr-1 expression in the cortex is driven by natural 
synaptic activity induced by physiological stimulation (for example the visual activity) (Worley et 
al., 1991). At protein level, Egr-1 protein is localized in cerebral cortex, hippocampus, thalamus, 
Figure 14 : Schematic representation of short region of Egr-1 promoter containing several regulatory 
elements:  two CRE binding sites, two SRE, and one GC box recognized by both SP-1 and Egr-1 itself.  
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amygdala, lateral septum and olfactory bulbs cortex   (Herdegen et al., 1990; Mack et al., 1990; 
Waters et al., 1990) 
At molecular level, Egr-1 induction occurs via different pathways. The most studied ones are the 
dopamine induced expression of Egr-1 due to the implication of Egr-1 in drug addiction 
mechanisms (Fritz et al., 2011; Hollis et al., 2012; Mutschler et al., 2000; Ziolkowska et al., 2011), 
and as previously described the glutamate induced CREB-dependent Egr-1 expression. Induction of 
Egr-1 trough NMDA receptors occurs mainly in the cortex, the hippocampus, the cerebellum and 
the olfactory bulbs (Beckmann et al., 1997). Cole’s team showed that Egr1 was rapidly induced by 
NMDA activation in mouse hippocampal neurons and in rat hippocampus by electroshock induced 
seizures (together with c-Fos, c-jun and junB) (Cole et al., 1989) . Egr-1 induction occurs via 
pharmacological activation but also after a wide range of behavioral stimulations. Egr-1 has been 
showed to be induced by non-intrusive methods as novel environment exploration (Guzowski et 
al., 2001), but also by more strong protocols as fear conditioning (Hall et al., 2001). Memory tests 
have also been related to Egr-1 induction in the cortex and hippocampus (Frankland et al., 2006).  
Egr-1 activity can also be repressed by interaction with NAB1 and NAB2  (NGFI-A binding protein) a 
family of corepressor constitutively expressed  (Russo et al., 1995).  
Function of Egr-1 
 
Egr-1 was clearly established has a plasticity marker since the 90’s, when Worley and coworkers 
discovered that Egr-1 expression was regulated by synaptic activity in rat neocortex.  Discovery of 
Egr-1 role in the learning processes came also for the study of songbird learning events that 
requires ZENK for song memorization in neocortex (Mello and Clayton, 1995). In murine models, 
the impairments in long term memory formation and late phase LTP of Egr-1 KO mice strongly 
supported the function of Egr-1 in memory formation (Jones et al., 2001). In the same way, Egr-1 
overexpression has a positive impact on memory formation as it facilitates the hippocampal 
synaptic plasticity as well as long-term spatial recognition memory (Penke et al., 2014) . Egr-1 is a 
transcription factors containing 3 zinc fingers regions that allow its binding to DNA  nucleotide 
sequence GCG(G/T)GGGCG ( called GC or EBE) (Christy et al., 1988; Crosby et al., 1991; Sukhatme 
et al., 1988). The Egr-1 protein contains also a negative regulatory element in the R1 region 
(Matheny et al., 1994; O'Donovan et al., 1999). In the cell, Egr-1 exists in two forms, a longer one 
of 82kDa is present in the nucleus and contains a nuclear localization signal regions (NLS), the 
  Introduction 
51 
 
other one of 54kDa miss the DNA binding activity and is cytoplasmic (Matheny et al., 1994) (figure 
15).  
 
 
 
Transcriptional activation or repression induced by Egr-1 is involved in many cellular mechanisms. 
A microarray analysis in a mouse model of Egr-1 overexpression reveals that it influences the 
transcription of genes involved in modification and degradation of proteins by the proteasome 
(James et al., 2006), phosphorylation, cell division, metabolism, sensory perception and metal ion 
transport (Baumgartel et al., 2009). Other studies on Egr-1 targeted transcriptome have been 
performed on other model as PC12 cells (Beckmann et al., 1997). In the brain, Egr-1 regulates 
expression of genes important for memory formation like synapsin I and synapsin II (Thiel et al., 
1994), GDNF (Shin et al., 2009) but also regulates Cdk5 activity modifying Tau phosphorylation (Lu 
et al., 2011).   
C-Fos 
c-Fos protein was discovered in fibroblast in which stimulation by growth factors to turn back into 
the cell cycle induced c-Fos expression in a very fast way (Greenberg and Ziff, 1984). C-Fos is a 
protein of 55kDa containing a “leucine zipper domain” that associates with Jun by 
homodimerization to form the actively active transcription factor AP-1 (Curran and Franza, 1988). 
Together, they recognize the TGACTC nucleotidic sequence. In the brain, c-Fos regulates the 
expression of many effector genes involved in memory consolidation as growth factors, 
transcription factors, signal transducers or cytoskeletal components (Guzowski, 2002). C-Fos 
protein is slightly expressed at basal level maybe due to the instability of its mRNA (Chaudhuri, 
1997). However, c-Fos induction upon stimulation is rapid (mRNA levels rise after 5 to 30 min) and 
transient (decline to baseline occurs in 1 to 2 hours) in the hippocampus (Cortés-Mendoza et al., 
2013). 
Figure 15 . Schematic representation of Egr-1 protein containing a regulatory region for NAB 
corepressor binding and three DNA bindin sites 
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Many stimuli have been described to induce c-Fos in neurons or in the brain. In PC12 neuronal cell 
lines, c-Fos is induced by Ca2+ entry trough Voltage-dependent calcium channels (L-VGCC) after a 
treatment with nicotinic acetyl chloride and KCl, leading to membrane depolarization (Greenberg 
et al., 1986). In the brain, c-Fos is also induced in response to seizures (Morgan et al., 1987) and 
upon visual stimulation (Chaudhuri et al., 2000).  While conventional c-Fos KO show severe 
developmental abnormality  (Johnson et al., 1992) and are not suitable to understand the function 
of this protein in the brain, the c-Fos central nervous system (CNS) specific KO show deficits in 
synaptic plasticity and defects in learning and memory (Fleischmann et al., 2003).  
Transcriptional regulation of c-Fos 
Cis-acting regulatory elements in c-Fos promoter are mainly located between 600pb of the 
proximal promoter sequence (Robertson et al., 1995). The two main response elements that 
control c-Fos expression are CaRE and SR (figure 16):   
- CaRE element: similar to CRE, CaCRE is located within 100 pb of transcription start site 
(TSS), and regulate Ca2+ dependent transcription of c-Fos (Sheng et al., 1988)  .  
- SRE element: firstly described to mediate c-Fos induction after serum treatment, SRE are 
also required to induce the Ca2+ dependent c-Fos transcription. Formation of a stable 
ternary complex containing both SRF and Elk1 improve the Ca2+ dependent 
transcriptional response in neurons (Xia et al., 1996). Activation by phosphorylation of SRF 
happen trough CaMK while ELK1 occurs via the glutamate-induced ERK pathway. 
As for other IEGs, the recruitment of CREB on gene promoter is followed by an interaction with 
CBP and the subsequent activation of gene transcription by two types of mechanism:  
- CBP presence on gene promoter is able to recruit the RNA PolII and the associated 
transcriptional machinery leading to gene transcription 
- Histone acetyltransferase activity associated to CBP will promote the acetylation of 
histones tails surrounding c-fos promoter and increase the transcription of the gene 
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Histone acetylation hypothesis has been supported by many studies. Firstly, Tsankova et al. 
showed that stimulation that triggers c-Fos expression was accompanied by an increase of histone 
acetylation at its promoter (Tsankova et al., 2007). Moreover, inactivation of CBP’s HAT activity in 
a transgenic mouse model impaired c-Fos induction in CA1 region of hippocampus (Korzus et al., 
2004). In this study, the loss of c-Fos induction by CBP dependent mechanisms could be reversed 
by treatment with TSA, suggesting that deacetylases are also regulating c-Fos transcription. The 
HAT/HDAC conflict at c-Fos gene promoter is also illustrated in the work of Sng et al., where 
inhibition of HDAC by intraperitoneal injection of TSA intensifies c-Fos transcription after kainate 
stimulation and is followed by an increase in histone H4 acetylation in the hippocampus (Sng et al., 
2005). Involvement of HDAC2 in c-Fos regulation was also described by Guan et al. who showed 
that IEGs are negatively regulated by HDAC2 but not HDAC1 (Guan et al., 2009). More recently, 
Park et al. showed that repeated electroconvulsive seizures (ECS) are followed by an increase in 
expression of  HDAC2, a subsequent decrease in histone H3 and H4 acetylation and a decline in c-
Fos (as other IEGs) expression in rat prefrontal cortex. ChIP experiments demonstrated a greater 
recruitment of HDAC2 at the c-Fos gene promoter after ECS repeated treatment, and HDACi were 
able to reverse effect on gene transcription (Park et al., 2014).  
BDNF 
The brain derived neurotrophic factor (BDNF) is a member of neurotrofin family that acts 
extracellularly as growth factor. BDNF is expressed ubiquitously but more predominantly in the 
brain with higher levels in the hippocampus, cerebral cortex and in basal forebrain (Conner et al., 
1997).This neurotrofin exerts pleiotropic effect in neurons from differentiation to dendritic growth 
Figure 16. Regulatory elements controlling c-Fos expression. C-Fos contains SRE and CaRE elements 
enabling its induction by MAPK pathway or by activity dependent activation of CREB (Flavell and 
Greenberg, 2008) 
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and neuron survival. BDNF counts numerous transcripts obtained from the alternative splicing of 
the Bdnf gene that contains at least nine different exons all individually spliced into a common 3’ 
exon that encodes mature BDNF.  Exon IX is located at the 3’ end and encodes pro-Bdnf (Aid et al., 
2007). Each of the non-coding exons owns a specific promoter that allows a complex regulation of 
Bdnf gene transcription. From the six alternative promoters and the IX exons, some are tissue 
specific while other are neuronal-activity dependent (Tapia-Arancibia et al., 2008) . Among them, 
transcription of Bdnf gene trough exon IV gives rise to a transcript that fulfills all the criteria of 
activity-dependent immediate early gene (Zheng and Wang, 2009). 
Among the role dedicated to BDNF, synaptic activity regulation and memory formation are really 
important in the brain (Mizuno et al., 2000). Mice that do not express BDNF show impaired LTP 
and deficit in hippocampal learning (Poo, 2001; Tyler et al., 2002) while the reexpression via 
adenoviruses vectors or the exogenous administration of BDNF are restoring learning and memory 
deficits. Even if the presence of multiple promoters makes difficult the study of the activity 
dependent of Bdnf gene expression, the team of Sakata et al. has been able to create a mouse 
strain that show a specific KO of Bdnf exon IV expression. Interestingly, those mice show problem 
in GABAergic transmission, deficit in certain type of LTP in the cortex (spike timing dependant 
synaptic potentiation, STDP) as well as depression like behavior (Sakata et al., 2013). In 
Alzheimer’s disease, a controversy exists about the level of BDNF detected in the serum of 
patients. While some show an increase of plasma levels of BDNF in AD patient (Angelucci et al., 
2010; Faria et al., 2014) others show a lower BDNF serum levels in AD  (Platenik et al., 2014; 
Ventriglia et al., 2013) . 
Regulation of Bdnf gene expression occurs on many promoters and trough the recruitment of a 
large number of transcription factors. Exon IV shows the more dynamic activity and shares many 
features with other IEGS in the way of induction. It contains three calcium dependent response 
elements (Zheng et al., 2011), which bind to several transcription factors:   
- Calcium response factor (CaRF) can fix CaRE1 (Tao et al., 2002) 
- Upstream stimulatory factors 1 and 2  (USF 1/2 ) bind CaRE2 (Chen et al., 2003b; Li et al., 
2010; Tabuchi et al., 2002) 
- CREB is known to associate with CaRE3 
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Transcriptional silencing of Bdnf is mediated by the methyl-CpG binding protein MeCP2 that binds 
to methylated CpGs and help the recruitement of other chromatin remodeling factors such as 
HDACs, REST, CoREST (Chahrour et al., 2008). Among them, HDAC2 is known to help chromatin 
condensation and successive repression of Bdnf  (Guan et al., 2009). Neuronal depolarization 
creating a calcium influx leads to the removal of MeCP2 from Bdnf promoter and a subsequent 
DNA demethylation (Chen et al., 2003a; Martinowich et al., 2003). In the same time, 
phosphorylation of CREB at serine 133 allow its interaction with the histone acetyltransferase CBP 
and the acetylation oh histones that leave the chromatin open for the recruitment of other 
transcription factors (figure17). (Cortés-Mendoza et al., 2013).  Regulation of Bdnf by histone 
acetylation is illustrated in the work of Sui, that show that LTP induction in medial PF cortex leads 
to global increase in histone H3 and H4 acetylation at Bdnf promoters (Sui et al., 2012). However, 
Bdnf exon I is described as more likely regulated by histone acetylation while Bdnf exon IV 
regulation occurs preferentially by DNA methylation mechanisms after NMDA stimulation (Tian et 
al., 2009).  
 
 
  
 
 
 
 
 
 
Figure 17:  Bdnf gene structure containing VIII exons and the transcriptional regulators associated to 
Bdnf exon IV  (CaRF : Calcium response factor, USF: upstream stimulatory factor) (Flavell and 
Greenberg, 2008)   
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ARC 
Activity regulated cytoskeleton-associated protein more commonly called Arc, is an effector 
protein that shows a highly dynamic expression correlating with neuronal activity (Guzowski et al., 
2001; Link et al., 1995; Lyford et al., 1995). After induction by synaptic activity, Arc mRNA is 
transported to dendrites where it is locally translated (Link et al., 1995; Lyford et al., 1995) . Arc 
protein is enriched at postsynaptic density where it exerts its activity by interacting with other 
proteins to change neuronal activity pattern and improve synaptic plasticity. Arc is able to 
consolidate LTP by regulating actin cytoskeletal dynamics, but interacts also with membrane 
proteins as endophilin and dynamin to regulate AMPA receptors endocytosis during synaptic 
depression.  Forcing Arc expression is followed by a decrease in AMPA receptors expression while 
in neurons obtained from Arc KO mice, expression of AMPA receptors at neuronal surface is 
enhanced (Chowdhury et al., 2006). Moreover, Arc KO animals show an increase of early-phase 
LTP with loss of late phase LTP followed by many deficits in long term memory while short term 
memory is not impaired (Shepherd et al., 2006). 
Many stimuli as exploration of a novel environment or behavioral tasks that deal with spatial 
memory, fear conditioning or operant learning are able to induce Arc expression in vivo (Fletcher 
et al., 2006; Guzowski et al., 2001). At molecular level, Arc expression is dependent of NMDA 
receptor activation (Link et al., 1995; Lyford et al., 1995). 
First description of Arc promoter has been given by Waltereit and coworkers, and explores the 2kb 
upstream the transcription start site (Waltereit et al., 2001). They described the presence of SRE 
and AP1 but fail to detect neither any CRE site nor the ability of this region to respond to elevated 
levels of AMPc concluding that other regulatory regions should be located upstream. Indeed, the 
study of a larger region of 10kb upstream allow the discovery of a group of response element in 
the -7kb region further called Synaptic Activity Response Element (SARE) (Kawashima,2009 ; 
Inoue, 2010). SARE is composed of three binding sites: CREB, Mef2 binding site (MRE) and SRF 
(figure 18 A&B). This well conserved region exerts a full transcriptional activity only when the 
three transcription factors are simultaneously bound. SARE is activated by both MAPK and CAMK 
dependent pathway even is SRF seems more important in this process (Pintchovski et al., 2009; 
Smith-Hicks et al., 2010).  
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D. Epigenetic alteration in Alzheimer’s disease 
As epigenetic mechanisms play a key role in brain function especially in memory processes, the 
idea has emerged in the last decade that cognitive decline observed in AD could be related to 
epigenetic dysergulation. Moreover, epigenetic processes are quite dynamic and environmentally 
dependent, so they are also potentially reversible by pharmaceutical treatment targeting the 
epigenome. In line with this, HDAC inhibitors are compounds that, despite their low selectivity, 
show encouraging effects in mice model of AD. In this part, I will address the effect of AD on 
histone acetylation, focus and the specific histone modifying enzymes deregulated in neurological 
disorders and review the effect of HDAC inhibitors (HDACi) on mice model of AD. Moreover, I will 
give some clue to understand how memory processes are epigenetically regulated.   
Epigenetic in mouse models of Alzheimer’s and effect of HDAC inhibitors 
A large number of mouse models recapitulating Alzheimer’s disease is available. By expressing 
gene mutations in these mice (in APP, PS or Tau gene), we induce lesions characteristic of AD 
making it a useful tool to study the onset of the disease. However, we need to be careful with 
those models as they are not totally in line with the predominant late onset, sporadic forms of AD 
that we observe in humans. Perturbation in histone acetylation level in those mice has been 
described, especially after stimuli, and the positive effect of HDACi is also recurrent in those 
models.  
Figure 18. A. Synaptic activity-dependant activation of ARC. B. SARE complex contains CREB,MEF2 and 
SRF  (Kawashima et al., 2014; Okuno, 2011). 
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In APP/PS1 mouse model, level of histone H4 acetylation was reduced by 50% compared to WT 
after fear conditioning. This differential level could be reverse by treatment with TSA prior to 
training, as well as freezing performance and LTP in CA1-CA3 region of hippocampus (Francis et al., 
2009) . In Tg2576 mice (overexpressing a mutant form of APP, APPK670/671L), the level of histone 
H3 and H4 were assessed and a decrease of histone H4 acetylation, but not H3, was observed in 
hippocampus. However, in hippocampal primary cultures, acetylation of histone H4 but also H3 
was diminished in Tg2576 mice. Treatment with the HDACi phenylbutyrate (PBA) was able to 
inverse this difference in histone acetylation in vitro and in vivo, but more remarkably, the 
treatment was also able to ameliorate cognitive deficits and reduce Tau pathology in this model. 
The authors explain this effect by the desinhibition of the expression of several synaptic markers 
as Glur1, PSD95 or MAP2 (Ricobaraza et al., 2009).  In an earlier work, reinstatement of fear 
learning was described after treatment with PBA in Tg2576 mouse model from 6 to 16 months of 
age (Ricobaraza et al., 2012) . As those mice show early development of Aβ pathology, 
improvement in memory after PBA could be due to an induction of Aβ clearance, the mitigation of 
reticulum endoplasmic stress, restoration of dendritic spines in hippocampus, maybe trough the 
elevated expression of certain genes. However, PBA exerts also a chaperone activity, unlike 
sodium butyrate (NaBu) that shows only an HDACi activity. By comparing the effect of those 2 
molecules, it appears that beneficial effects on Tg2576 mice are restricted to PBA, asking whether 
PBA neuroprotective action could be independent of its HDACi activity (Cuadrado-Tejedor et al., 
2013).  
Treatment with the HDACi SAHA (suberanilohydroxamic acid also called Vorinostat) in the same 
model of Tg 2576 mice gives also contradictory results: while intra peritoneal (ip) injection of SAHA 
failed to improve cognitive function even if it facilitates LTP, direct intra hippocampal injections 
help memory impairments in aged mice (Hanson et al., 2013; Peleg et al., 2010) This differential 
effect could be due to the way of administration of the drug and the poor ability of SAHA to cross 
the blood brain barrier.  
In a third mouse model of AD, APPswe/PS1dE9, showing pronounced contextual memory 
impairments since 9 months of age, treatment with several HDACi (sodium valproate, sodium 
butyrate, vorinostat) was restoring contextual memory formation in long period of time (2 weeks), 
and especially when class I HDACs where inhibited (Kilgore et al., 2010).  
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By studying specific positions differentially acetylated in the hippocampus and cortex of APP/PS1-
21 mice by immunohistochemical quantification, Govindarajan et al. show that in different brain 
regions, the level of acetylation of histone H3K9,H3K14, H4K5,H4K12 and H4K16 were decreased 
in transgenic mice. They tested the effect of NaBu in old mice long after the onset of the illness 
and showed an improvement of memory function related to an increase in gene expression in the 
hippocampus but not in the cortex (Govindarajan et al., 2011) . 
HDACi treatment also reinstate learning behavior in a mouse model of neurodegeneration (CK-
p25) caused by overexpression of p25, a pathological activator of tau kinase Cdk5. Those mice 
show both Aβ and tau pathology, but intracerebroventricular injection of sodium butyrate during 4 
weeks rescued behavior and synaptic plasticity even after the onset of neuronal loss . 
Interestingly, WT mice submitted to a long term enriched environment (4 weeks) show 
comparable cognitive improvement, accompanied by an increase in histone acetylation and 
methylation in hippocampus and cortex (Fischer et al., 2007).  
Histone modifying enzymes in AD 
HDAC1  
HDAC1 belongs to class I of HDAC and is mainly nuclear. HDAC1 is upregulated in brain of patients 
suffering  schizophrenia (Benes et al., 2007; Sharma et al., 2008) and Huntington disease (Quinti et 
al., 2010) but not  Alzheimer’s disease. However, HDAC1 could be involved in AD pathogenicity 
because it is critical to mediate genome stability, loss of HDAC1 leading to DNA damages (Kim et 
al., 2008). Even if HDAC1 KO animals do not show any memory deficits (Guan et al., 2009), HDAC1 
overexpression in hippocampus leads to impairments of extinction of fear memory, and HDAC1 is 
required for extinction learning by mechanisms that involve H3K9 deacetylation (Bahari-Javan et 
al., 2012). HDAC1 specific inhibitor Etinostat has been show to improve the deregulation of resting 
behavior show in APP/PS1 mice and decrease neuroinflammation and plaque depositions in those 
mice (Zhang and Schluesener, 2013). Furthermore, in a CK-p25 model of degeneration, elevated 
levels of HDAC1 induce neuronal cell death in a HDAC3 dependent-way (Bardai et al., 2012).  
HDAC2 
In 2009, a study of Guan et al. shows that HDAC2 negatively regulates memory formation (Guan et 
al., 2009). In this paper, authors showed that overexpression of HDAC2 was leading to memory 
impairments, and had negative impact on neuronal synaptic plasticity markers as spine density. 
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Moreover, analysis of promoter occupancy revealed an association of HDAC2 with the promoters 
of genes implicated in synaptic plasticity and memory formation as Egr-1, c-fos, Bdnf ex IV. 
Another study on HDAC2 conditional KO confirmed that the loss of HDAC2 improves working 
memory (Morris et al., 2013). In Alzheimer’s disease, discrepancies exist in the literature about the 
level of HDAC2 : Graff et al. refer an increase of HDAC2 levels in hippocampus and entorhinal 
cortex from stage I/II (Graff et al., 2011), while Mastroeni et al. show reduced HDAC2 levels in AD 
brain cortical area (Mastroeni, 2010). In neurodegenerative brain, HDAC2 is increased in neuronal 
nuclei of CA1 in both CK-p25 and 5xFAD. This global up-regulation is followed by an enrichment of 
HDAC2 and a decrease of histone H4K12 acetylation at memory related genes promoters (of which 
egr1 and Bdnf). Interestingly, treatment of neuronal cell with Aβ42 was able to increase the global 
level of HDAC2 (Graff et al., 2012). 
HDAC 3 and HDAC4 
HDAC3 and HDAC4 could act together or share a role in the regulation of object memory (Fischle 
et al., 2002). Deletion of HDAC3 in hippocampus is followed by an increase of histone H4K8 and 
up-regulation of c-Fos and Nr4a2 (McQuown et al., 2011). Furthermore, HDAC3-specific inhibitor 
RGF933 administration affects histone H3K14 and H4K8, but not H2B acetylation in infralimbic 
cortex, and improves object memory (Malvaez et al., 2013).  
HDAC5  
Role of HDAC5 in memory decline was studied in APP/PS1-21 mouse model, where loss of HDAC5 
accelerates memory decline (Agis-Balboa et al., 2013).This could be due to the ability of HDAC5 to 
be shuttled out of the nucleus after axonal damages, enabling transcription of axonal regeneration 
gene program (Cho and Cavalli, 2012).  
HDAC6 
HDAC6 seems to be responsible for Tau deacetylation (Ding et al., 2008), while acetylation of Tau 
could be mediated by an intrinsic enzymatic activity, making it capable of catalyzing self-
acetylation (Cohen et al., 2013). Question of positive or negative effect of Tau acetylation is still 
debating. Neuropathological Tau acetylation has been described in AD, where acetylation of Tau at 
lysine 280 in a specific microtubule binding domain (MTBD) results in a decrease in microtubule 
binding and in increase in fibrillization of Tau (Irwin et al., 2012). Therefore, abnormal Tau 
acetylation would be a pathological post-translational modification contributing to tau-mediated 
neurodegeneration (Irwin et al., 2013). Although interaction of Tau with HDAC6 leads to Tau 
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clearance (Ding et al., 2008; Perez et al., 2009), Cook et al. show that deacetylation of Tau make it 
more vulnerable to phosphorylation, thus more toxic (Cook et al., 2014) and studies in drosophila 
and AD mouse model suggest that inhibition or loss of HDAC6 might attenuate tau pathology and 
rescue memory functions (Govindarajan et al., 2013).  
Sirt1 
In vivo, lentiviral mediated overexpression of SIRT1 confers substantial protection against 
neurodegeneration in mouse model of AD (Kim et al., 2007), but deacetylase activity is not specific 
to histone and the effect could be due to the action of SIRT1 on other proteins.  
CBP 
Even if mutations on CBP is associated to another neurological disease (Rubinstein-Taybi 
syndrome), data on CBP expression in AD are scarce. However, relation between CBP expression 
and presenilins has been studied lately. First, Caccamo et al. show that phospho CREB levels are 
downregulated in a mouse model of AD, where overexpression of CBP ameliorates memory 
impairments (Caccamo et al., 2010). On the contrary, in neuronal culture, mutated PS1 inhibit 
proteosomal degradation of CBP and this result in an increase in CREB dependent gene expression 
(Marambaud et al., 2003). Unbalanced gain of transcription of CREB target genes will be caused by 
FAD mutations. CBP seems also activated by PS only in its normal form, while mutation in PS1 and 
PS2 cause decrease in CBP levels and CREB dependent gene expression in cerebral cortex (Francis 
et al., 2007). Conditional double knockout mice lacking presenilins in the forebrain exhibit 
impairments in hippocampal synaptic plasticity and spatial contextual memory,decrease in 
expression of CBP and CREB target genes as Egr1, Fos and Bdnf. Activation of the APP signaling 
pathway with an antibody directed against the extracellular domain of APP in order to promote 
cell  death   in primary cortical neurons leads also to an overall decrease in histone H3 and H4 
acetylation as well as a decrease in CBP levels (Rouaux et al., 2003).  
Tip60 
Tip 60, as explained previously, is closely related to gene transcription regulation by AICD (Cao and 
Sudhof, 2001; Müller et al., 2007). However, little is known about Tip60 implication in AD and 
about gene regulated by this HAT. It seems that Tip60 is implicated in cell response to DNA 
damages (Kaidi and Jackson, 2013) and could also acetylate Tau (Sarthi and Elefant, 2011). 
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AIM	OF	THE	WORK		
As highlighted in the introduction, many teams worldwide have studied the implication of APP in 
the regulation of gene transcription and have suggested mechanisms underlying these regulations 
(Baek et al., 2002; Belyaev et al., 2009; Checler et al., 2010; Huysseune et al., 2009; Kim et al., 
2003; Li et al., 2010; Müller et al., 2007; Pardossi-Piquard et al., 2005; von Rotz et al., 2004). 
Similarity between APP and Notch processing by γ-secretase activity founded the attractive 
hypothesis of gene regulation by the APP intracellular domain (AICD). However, the question of 
the ability of APP and in particular AICD to regulate target genes remains debated (Aydin et al., 
2011; Chen and Selkoe, 2007; Hébert et al., 2006; Waldron et al., 2008; Yang et al., 2006).  
Given these conflicting reports, we were interested to study in detail the ability of APP to regulate 
gene transcription. 
The starting point of my work was the observation performed by S. Huysseune who showed an 
APP-dependent regulation of AQP1 expression.  The major finding of her work was that AQP1 
expression was differentially sensitive to the HDACs inhibitor TSA in absence or presence of APP, 
and that HDAC activity was associated with AICD (Huysseune et al., 2009). Furthermore, other 
kinds of epigenetic regulation of gene expression by APP have been proposed and seem of a 
particular interest (Belyaev et al., 2009; Kerridge et al., 2014). 
Using a model of mice expressing or not APP, we identified new target genes of APP, studied the 
mechanisms involved in APP-mediated regulation of transcription and the relevance of this 
regulation in physiological conditions.  
Three different issues were addressed:  
- Is APP able to regulate gene expression in vitro and in vivo, and which are the mechanisms 
involved in this regulation?   
- Does APP-mediated regulation of gene transcription involves epigenetic changes at the 
level of gene promoters?  
- Has APP-mediated regulation of gene transcription a physiological relevance? 
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RESULTS 
In order to discover new target genes of APP, we performed a microarray analysis on mRNA 
isolated from primary culture of astrocytes derived from APP +/+ and APP-/- mice. Among the list 
of genes differentially expressed in absence or presence of APP, we decided to focus our effort on 
the study of Egr-1, a transcription factor belonging to the family of Immediate Early genes, playing 
an important role in the cascade of events underlying memory formation. 
In a first step, we extended the observation made in astrocytes to neurons, where we confirmed 
the APP dependent transcription of Egr-1 at early stages of maturation. Indeed, Egr-1 mRNA and 
protein were reduced in presence of APP in primary cultures of neurons. AICD involvement in this 
regulation was then assessed by treating neurons with a γsecretase inhibitor and by chromatin 
immunoprecipitation (ChIP) using antibodies raised against the C-terminal domain of APP to 
evaluate a possible link of AICD to Egr-1 promoter. We came to the conclusion that AICD was not 
involved in regulation of Egr-1 transcription, and did not bind to the Egr-1 gene promoter.  
Knowing that Egr-1 is controlled by epigenetic mechanisms and especially histone acetylation, we 
concentrated our research on the effect of APP on acetylation of histone surrounding Egr-1 
promoter. ChIP assay enabled us to evaluate pan-acetylation of histone H3 and H4 in APP+/+ and 
APP-/- neurons, where we noticed that histone H4 was systematically overacetylated at Egr-1 
promoter in APP-/- neurons, arguing for an epigenetic regulation of Egr-1 by APP. 
In a second step, we moved to a model of young adult mouse APP+/+ and APP-/-, where we 
studied APP dependent regulation of Egr-1 in prefrontal cortex in basal conditions but also after 
stimulation (here exposure to novelty in an open field). Similarly to neurons, we found an 
overexpression of Egr-1 in APP-/- prefrontal cortex, together with an enrichment of acetylated 
histone H4 at Egr-1 gene promoter.   
As expected, exposition to novelty was followed by an increase in Egr-1 transcription in APP+/+ 
mouse prefrontal cortex, but not in APP-/- mice where Egr-1 was already overexpressed as 
compared to APP+/+ littermates.  Acetylation of histone H4 at Egr-1 promoter was also increased 
after exposure of APP+/+ but not APP-/- mice to novelty. 
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From these observations, we conclude that APP was necessary for the epigenetic induction of Egr-
1 by novelty, and these mechanisms could be involved in the memory deficits observed later in 
APP -/- mice. 
Finally, we had the opportunity to assess the level of Egr-1 protein in the cortex of healthy and 
Alzheimer’s disease (AD) patients. According to the literature, the level of Egr-1 protein measured 
was systematically higher in the samples coming from AD patients.  
These results have been published in the paper presented in the next pages.  
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I. Epigenetic	induction	of	EGR-1	expression	by	
the	amyloid	precursor	protein	during	
exposure	to	novelty	
 
Aurélie Hendrickx , Nathalie Pierrot , Bernadette Tasiaux , Olivier Schakman, Jean-Pierre 
Brion, Pascal Kienlen-Campard, Charles De Smet & Jean-Noël Octave.   
 
PLOS ONE | September 2013 | Volume 8 | 
Issue 9 | e74305 
A. Abstract	
Following transcriptome comparison of primary cultures isolated from brain of mice expressing or 
not the amyloid precursor protein APP, we found transcription of the EGR-1 gene to be regulated 
by APP. In primary cultures of cortical neurons, APP significantly down regulated EGR-1 expression 
at both mRNA and protein levels in a γ-secretase independent manner. The intracellular domain of 
APP did not interact with EGR-1 gene promoter, but enrichment of acetylated histone H4 at the 
EGR-1 promoter region was measured in APP-/- neurons, as well as in brain of APP-/- mice, in 
which increase in EGR-1 expression was also measured. These results argue for an important 
function of APP in the epigenetic regulation of EGR-1 gene transcription both in vitro and in vivo. 
In APP-/- mice, constitutive overexpression of EGR-1 in brain impaired epigenetic induction of this 
early transcriptional regulator during exposure to novelty. Altogether, these results indicate an 
important function of APP in the epigenetic regulation of the transcription of EGR-1, known to be 
important for memory formation 
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B. Introduction 
Among the various functions that have been attributed to APP, regulation of gene expression has 
been widely investigated due to similarity between Notch and APP processing.  The γ-secretase 
cleavage of APP and Notch releases the APP intracellular domain (AICD) and the Notch 
intracellular domain (NICD), respectively. Processing of Notch is initiated by binding of the Delta 
ligand on one cell to the Notch receptor on another cell resulting in two proteolytic cleavages of 
the receptor. The α-secretase cleavage generates a substrate for cleavage by the γ-secretase 
complex. This proteolytic processing mediates release of the NICD, which enters the nucleus to 
regulate transcription [1]. APP has all the characteristics of a type1 transmembrane receptor, and 
interacts with many proteins via its extracellular domain [2]. APP and Notch are processed by the 
same secretase activities and APP has been suggested to control transcription of several genes [3-
8]. To study regulation of gene transcription by APP, transcriptomes of primary cultures isolated 
from brain of APP+/+ and APP-/- mice from the same genetic background were compared using 
the affymetrix microarray technology, and we identified EGR-1 as a possible target gene controlled 
by APP.  
EGR-1 (also called Zif 268, Krox24, NGFI-A) is a an early growth response gene, member of the zinc 
finger family of transcription factors that displays fos-like induction kinetics in many cells including 
neurons. EGR-1 regulates transcription of late response genes important for the synaptic plasticity 
processes, especially the maintenance of long-term potentiation [9]. In mouse brain, EGR-1 is 
constitutively expressed in the cortex but is rapidly induced in the prefrontal cortex and 
hippocampus after several stimuli as exposure to novelty, fear conditioning or recognition task. 
[10-12].In addition, EGR-1 up regulates presenilin-2 gene expression in neuronal cells [13], and 
consequently the γ-secretase cleavage of APP.  Moreover, EGR-1 is up regulated in the brain of 
patients with Alzheimer disease (AD), and overexpression of EGR-1 controls both phosphorylation 
and dephosphorylation of tau, by activating CDK5 and inactivating PP1, leading to tau 
hyperphosphorylation and destabilized microtubules [14]. For all these reasons, we were 
interested to study how APP is involved in the regulation of EGR-1 gene transcription.   
Our results indicate that both in cultured neurons and in vivo, APP affects EGR-1 expression by 
modulating enrichment of acetylated histone H4 on the EGR-1 gene promoter, and therefore 
participates to the epigenetic regulation of EGR-1 expression. The constitutive overexpression of 
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EGR-1 in APP -/- mice impairs induction of this early transcriptional regulator during exposure to 
novelty.  
C. Material and methods 
Cell culture and pharmacological treatments 
Primary cultures of cortical astrocytes were prepared from newborn p-0/p-1 mice pups as 
previously described [15].  APP +/+ and APP -/- pups from the same littermate were genotyped 
and sexed.  Briefly, cortices were isolated and dissociated in Dulbecco’s modified Eagle medium 
DMEM (glutaMAX) supplemented with 10% (FBS), proline (50 mg/ml), penicillin-streptomycin (50 
mg/ml), and fungizone (2.5 mg/ml). After centrifugation, cells were seeded into culture flasks 
grown at 37°C in a 5% CO2 atmosphere during 7 days. At this time point, culture flasks were 
vigorously shaken to eliminate cell debris, microglia, and oligodendrocytes. Three days later, cells 
were plated at 104 cells/cm² in culture dishes pre-treated with 10mg/ml poly-L-lysine in PBS.  
Primary cultures of cortical neurons were performed on p-0/p-1 newborn pups from APP +/+ and 
APP -/- mice. Briefly, cortices were digested in trypsin/DNAse medium (PBS containing 10 mg/ml 
trypsin; 1mg/ml DNAse; 6mM NaOH). Then, they were dissociated with a glass pipette in 
Neurobasal medium supplemented with 2% v/v B27 medium, 0.5% L-glutamine, 0.1% Pen-strep.  
All reagents were obtained from Invitrogen. Cortical neurons were grown on 6 or 12 wells culture 
dishes pre-coated with 10 µg/ml poly L-Lysine, at a density of 4x10
5
cells/cm
2
 and cultured during 5 
days in Neurobasal medium. On day 4, neurons were treated 24h with the HDACs inhibitor, 
trichostatin A at final concentration of 25ng/ml (Sigma) or vehicles. Neurons at DIV5 were treated 
during 8h with DAPT (250 nM) a functional γ-secretase inhibitor.  
Animals and tissue samples 
The APP+/+ and APP -/- mice used in this study were C57Bl/6J obtained from The Jackson 
laboratory and backcrossed for more than 5 generations in the CD1 genetic background. The 
open-field test was used to assess the exposure of mice to a new environment. Mice had access to 
food and water ad libidum, and they were moved to the experimental platform animal house one 
week before the open field (OF). Mice were exposed to open field area during 15 min and then 
sacrificed 30 min after this exposure to enable the expression of EGR-1. All manipulations on mice 
have been approved by the local ethics committee of the catholic University of Louvain and follow 
the European legislation. 
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Postmortem human brains (n=6) were collected with the approval of the Ethical Committee at the 
Medical School of the Free University of Brussels and have been described previously [16]. One 
hemisphere was frozen in liquid nitrogen and stored at -80°C for biochemical analysis. The other 
hemisphere was fixed by immersion in 10% formalin (v/v) for neuropathological analysis.  
RNA extraction and quantitative real time PCR 
Total RNA was purified using Trizol method (Tripure, Roche). Reverse transcription (RT) and 
quantitative (q) real time PCR (q-RT PCR) were respectively performed with the iScript cDNA 
synthesis Kit and the iQ SYBR Green supermix using a iCycler MyIQ2 multicolor Real-Time PCR 
detection system (Biorad). The relative amplification of cDNA fragments was calculated by the 2-
∆∆Ct method.  q-RT PCR primer sequences used were as follows:  EGR-1 forward : 
TCCTCTCCATCACATGCCTG, EGR-1 reverse: CACTCTGACACATGCTCCAG, GAPDH forward: 
ACCCAGAAGACTGTGGATGG, GAPDH reverse: ACACATTGGGGGTAGGAACA. 
Protein analysis 
Cells or powdered frozen tissues  were lysed in a Laemmli buffer (125mM Tris pH 6.8, 20% 
glycerol, 4% SDS) with complete protease inhibitor cocktail (Roche).  For nuclear extraction, 
material was lysed in 0.25 M sucrose buffer (sucrose 0.25 M, Tris 50mM, EDTA 1mM, imidazole 
3mM, pH 7.0 + proteases inhibitor cocktail) , and centrifuged 10 min at 250g. Nuclear fraction was 
resuspended in Laemmli buffer.  Western blotting was performed on 10 µg of protein lysates. All 
samples were sonicated before protein assay (BCA Pierce, Thermoscientific), incubated during 5 
min at 95°C in Laemmli containing DTT and staining blue (Nupage blue, Invitrogen), loaded onto 4–
12% NupageTM bis-Tris gel electrophoresis (Invitrogen), and then transferred to nitrocellulose 
membranes (Amersham Biosciences). Membranes were incubated overnight at 4°C on a wheel 
with the primary antibodies; anti-APP C-ter 1:3500  (kind gift of N. Sergeant, INSERM U422, Lille, 
France) , anti-EGR-1 1:1000 (sc-110 Santa Cruz) , anti-tubulin 1:6500 (Sigma). Washes with PBS-
Tween (0.005%) were followed by incubation with secondary antibody (1:10 000 anti-mouse or 
anti-rabbit IgG) (GE Healthcare) coupled to horseradish peroxidase and revealed by ECL. For 
quantification, the membranes were stripped and reincubated with an anti-tubulin. 
Immunoreactive bands were quantified with an electrophoresis Gel Doc 2000 imaging system 
coupled to a Quantity one™ software (Bio-Rad).   
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Aβ measurement by ECLIA 
We measured the concentration of mouse Aβ 40 in culture medium from neurons treated or not 
with DAPT. Samples were centrifuged at 12000g during 3 min at 4°C, and Aβ 40 was quantified in 
25 µl of culture medium by multiplex Electro-Chemiluminescence Immuno Assay (ECLIA) (Meso 
scale Discovery), analyzed with the  Meso Scale Discovery (MSD) SECTOR™ Imager 2400 according 
to manufacturer’s instructions. 
Chromatin immunoprecipitation 
Chromatin immunoprecipitation was performed on cortical neurons (day 5) or mice cortices using 
the EZ-ChIP Assay kit (Millipore) according to manufacturer instructions. Cortices were powdered 
in liquid nitrogen and DNA-protein interactions were directly cross-linked by the addition of a 37% 
v/v of formaldehyde 37% (Sigma) into PBS 1X containing protease inhibitor cocktail during 20 
minutes.  Cells seeded in 6 wells plaques were pelleted and resuspended in Dulbecco modified 
Eagle’s medium (DMEM) before crosslink with formaldehyde 37% during 10 minutes. The 
crosslinking reaction was stopped by adding glycine.  After several washes with cold PBS and 
resuspension in SDS lysis buffer containing inhibitors of proteases, samples were sonicated in 
order to shear the cross linked chromatin. Conditions of sonication were experimentally adapted 
given the cell type, culture conditions, and equipment.  Cells and brains were sonicated in an ice 
bath at high power and a series of 30 cycles of 30 s for neurons and 25 cycles for cortices, and 
were performed with a sonicator “Bioruptor® UCD-20’” (Diagenode). The samples were kept on 
ice during 30 s between two pulses. Verification of sheared DNA on 1.2% agarose gel was realized 
after incubation of an aliquot with RNAse A at 37°C during 30 min and with proteinase K at 65°C 
during two hours. We obtained a sheared DNA with an average size of fragments between 400 
and 200 pb. An aliquot of precleared DNA was collected as the input. The samples were then pre-
cleared with ChIP blocked protein G agarose and incubated overnight at 4°C with the antibodies of 
interests (5μg anti-AcH3 (07-690 Millipore); 5μg anti-AcH4 (06-599 Millipore); 10µl anti-APP Cter 
serum (kind gift of N.Sergeant) or 10µg of the commercially available anti-APP Cter antibody 
(A8717 Sigma). After immunoprecipitation, the DNA–histone complex was collected with 40 µl of 
ChIP blocked protein G agarose beads for 1h. The beads were sequentially washed once with low 
salt, high salt, and LiCl and washed twice with 10 mM Tris (pH 8)/1 mM EDTA buffers. DNA was 
finally collected with spin filters, and the immunoprecipited DNA was analyzed by qPCR with 
primers designed to amplified short regions of the promoters of genes of interest. 
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qPCR primers were as follows: EGR-1 forward: GTGCCCACCACTCTTGGAT, EGR-1 reverse: 
CGAATCGGCCTCTATTTCAA, GAPDH forward: AGAGAGGGAGGAGGGGAAATG, GAPDH Reverse: 
AACAGGGAGGAGCAGAGAGCAC. The quantification method used is based on the ratio between 
immunoprecipitated DNA and input DNA. The method was validated by the amplification of the 
well characterized GAPDH gene. 
Statistical analysis 
All results are expressed as mean ± standard error (SE) values. Statistical significance was 
determined by one-way or two-way analysis of variance (ANOVA) followed by Bonferroni’s 
multiple comparisons test for multi-group comparison and the student’s t-test for two-group 
comparisons. 
D. Results 
Transcriptome comparison of primary cultures isolated from brain of APP+/+ and 
APP-/- mice. 
High quality RNA was prepared from expanded primary cultures of astrocytes from APP+/+ and 
APP-/- mice from the same genetic background, and utilized in the Affymetrix platform for 
transcriptome comparison. As a positive control, APP appeared more than strongly expressed in 
APP+/+ astrocytes. In addition to APP, a list of genes with up regulated transcription in APP+/+ 
astrocytes is presented in table 1. Transcription of several genes was also up regulated in APP-/- 
astrocytes (table 1). Although up regulation of EGR-1 gene transcription in APP-/- cells was not 
impressive, this gene encodes an early transcription factor involved in memory formation, and we 
further investigated the regulation of EGR-1 expression by APP in primary cultures of cortical 
neurons.   
APP down regulates neuronal EGR-1 expression both at the mRNA and protein 
levels.   
To confirm data obtained from the comparison of transcriptomes using Affymetrix technology, 
primary cultures of cortical neurons from APP+/+ and APP-/- mice from the same genetic 
background were analyzed using q-RT PCR and western blotting. Results presented in figure 1A 
indicate that EGR-1 mRNA was significantly more abundant in APP-/- than in APP+/+ neurons.  At 
the protein level, a significant decrease in EGR-1 was also quantified in APP+/+ as compared to 
APP-/- neurons (Figure 1B). From these results, we conclude that APP down regulates neuronal 
EGR-1 expression both at the mRNA and protein levels.  
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Table 1:  Microarray data. 
mRNA from APP+/+ and APP-/- 
astrocytes was utilized in the 
Affymetrix platform for 
transcriptome comparison. Genes 
are notified by gene symbol and 
increase in gene transcription is 
indicated as fold changes in APP+/+ 
or APP-/- astrocytes.  
 
  Results 
74 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
APP-mediated regulation of EGR-1 expression is independent of the γ-secretase 
cleavage. 
Since the intracellular domain of APP (AICD) is a transcriptional regulator, we next studied whether 
it could account for APP-dependent repression of EGR-1 gene transcription. Rescue of APP by 
adenoviral expression of APP or APP deleted from AICD in APP-/- neurons did not allow us to 
conclude. Unfortunately, up regulation of EGR-1 expression in these experimental conditions was 
proportional to the adenoviral load rather than to the protein expressed (data not shown). 
Therefore, we decided to inhibit AICD release by the γ-secretase inhibitor, DAPT [17], which 
Figure 1  : APP regulates EGR-1 expression at both mRNA and protein level.  
A)  EGR-1 mRNA levels were quantified by q-RT PCR in APP+/+ and APP-/- neurons DIV5 (n=9 
cultures). Values were normalized to the GAPDH mRNA, and expressed as percentage of APP+/+. 
Student’s t-test : **p<0.005. B) EGR-1 protein was detected by Western blots of total and nuclear 
extracts obtained from primary culture of neurons DIV5 (n=3). APP was detected in APP+/+ neurons 
with an anti-APP C-terminal antibody, EGR-1 was detected with sc-110 antibody and anti-tubulin 
antibody was utilized for loading control. ***p<0.001 . Data are expressed as mean ± SEM.  
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induced a very strong accumulation of APP C-terminal fragments in APP+/+ neurons (Figure2A), 
resulting from the inhibition of the γ-cleavage of APP. DAPT did not affect APP-mediated down 
regulation of EGR-1 mRNA levels (Figure 2C). In addition, the γ-secretase inhibitor decreased by 50 
% Aβ secretion (Figure 2B), without affecting EGR-1 mRNA levels in APP+/+ neurons. We then 
performed chromatin immunoprecipitation assays using antibodies raised against the C-terminal 
domain of APP (AICD). These antibodies failed to enrich EGR-1 promoter sequences in both 
APP+/+ and APP-/- neurons (Figure 2D). Altogether, these results rule out that APP-mediated 
decrease in EGR-1 mRNA levels is γ-secretase dependent, and indicate that EGR-1 expression is not 
regulated by extracellular Aβ. In addition, AICD does not interact with the EGR-1 promoter.   
Acetylated histone H4 is enriched on the EGR-1 gene promoter in APP-/- neurons. 
Epigenetic regulation of EGR-1 gene transcription has been previously demonstrated, in particular 
by modulation of enrichment of acetylated histones on the EGR-1 promoter by HDAC 2 activity 
[18]. Chromatin immunoprecipitation assays using anti-acetylated histone antibodies showed that 
acetylated histones H3 and H4 were enriched at the EGR-1 gene promoter, but acetylated histone 
H4 was more enriched in APP-/- neurons (Figure 3A). Consistent with the notion that acetylation 
of histones opens chromatin and improves gene transcription, more acetylated histone H4 at the 
EGR-1 promoter could improve EGR-1 expression in APP -/- neurons. These results demonstrate 
that APP significantly decreases enrichment of acetylated histone H4 at the promoter of EGR-1 
gene, leading to reduced EGR-1 gene transcription. A difference in histone acetylation at the 
promoter of EGR-1 gene should influence the effect of an HDAC inhibitor on EGR-1 gene 
transcription in APP+/+ and APP-/- neurons. To test this hypothesis, the effect of trichostatin A 
(TSA) on EGR-1 gene transcription was investigated in both APP+/+ and APP-/- neurons. Results 
presented in figure 3B indicate that TSA was able to induce EGR-1 transcription in both APP+/+ 
and APP-/- neurons, although induction was significantly higher in APP-/- neurons, in agreement 
with higher H4 acetylation at the EGR-1 promoter in these cells.  
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Figure 2 : Pharmacological inhibition of γ-secretase does not affect APP-mediated control of 
EGR-1 expression. 
A) Western blot analysis of cellular extracts from control neurons (Ctl) or neurons treated for 8h with 
250nM DAPT (DAPT). APP and APP CTF were detected by with an antibody raised against the C-terminal 
domain of APP. B) Aβ was quantified in the culture medium of APP+/+ or APP-/- neurons treated (DAPT) 
or not (NT) for 8h with 250nM DAPT. C) EGR-1 mRNA levels were quantified by q-RT PCR on APP +/+ and 
APP-/- neurons DIV5 treated (DAPT) or not (NT) for 8h with 250nM DAPT (n=3). Values were normalized 
to the GAPDH mRNA, and expressed as percentage of APP+/+.Results are expressed as mean ± SEM. D) 
Chromatin immunoprecipitation of EGR-1 promoter was performed on chromatin isolated from APP+/+ 
and APP-/- neurons DIV5 (n=3) using normal mouse IgG as negative control (IgG) and two different anti-
C-terminal APP antibodies: anti-AICD homemade (HM) or commercial (C).  Immunoprecipitated DNA was 
quantified by qPCR, and normalized to the input.  
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Figure 3 : Epigenetic regulation of EGR-1 gene expression by APP.  
A. Fragmented chromatin obtain from APP+/+ and APP-/- neurons DIV5 (n=3) was immunoprecipitated with 
antibody recognizing normal mouse IgG as negative control (IgG), anti-acetylated histone H3 (H3Ac) or anti-
acetylated histone H4 (H4Ac). Quantification was realized by real-time qPCR performed on 
immunoprecipitated DNA with primers designed on EGR-1 promoter, and normalized to the input. n.s. non-
significant. ***p<0.001. B. EGR-1 mRNA levels were quantified in APP+/+ and APP-/- neurons DIV5 treated 
(TSA) or not (NT) for 24 h with 25ng/ml TSA (n=6). Values were normalized to the GAPDH mRNA, and 
expressed as percentage of APP+/+. Two way Anova. **p<0.005, ***p<0.001. Relative induction of Egr-1 
after exposure to TSA after normalization. Student t test. *p<0.05 
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In vivo regulation of EGR-1 expression by APP.  
To further investigate whether APP-mediated regulation of EGR-1 expression in cultured neurons 
was relevant in vivo, cerebral cortices of APP+/+ and APP-/- mice were analyzed in q-RT PCR and 
western-blotting. Results presented in figure 4A clearly demonstrate up regulation of EGR-1 mRNA 
levels in brain of APP-/-, which was very similar to that observed in cultured neurons. At the 
protein level, a significant increase in EGR-1 was also measured in brain of APP-/- mice (Figure 4B). 
To investigate whether APP-mediated down regulation of EGR-1 in vivo could occur at the 
epigenetic level, chromatin immunoprecipitation assays were performed on brain samples from 
APP+/+ and APP-/- mice. Results presented in figure 4C indicate that acetylated histone H4 was 
more enriched at the EGR-1 gene promoter in APP-/- than in APP+/+ brain, confirming results 
obtained in cultured neurons. Altogether, these results allow us to conclude that APP participates 
in the epigenetic regulation of EGR-1 gene transcription both in vitro and in vivo.  
Physiological relevance of APP-mediated regulation of EGR-1 expression.  
Several studies indicate that immediate early genes, and in particular EGR-1, play an important 
role in learning and memory processes, and that EGR-1 expression is rapidly up regulated during 
exposure to novelty [19].Therefore, APP+/+ and APP-/- mice were exposed or not to an open field 
during 15 minutes and EGR-1mRNA levels were thereafter quantified in the cerebral cortex. 
Results presented in figure 5A  indicate a significant induction of EGR-1 gene transcription in 
APP+/+ but not in APP-/- mice, suggesting that constitutive high expression of EGR-1 in APP -/- 
mice could impair induction of this early transcriptional regulator during exploration behavior. 
Moreover, exposure to novelty induced significant enrichment of histone H4 acetylation on EGR-1 
promoter region only in APP+/+ mice (Figure 5B). All together, these results indicate that APP is 
needed to induce epigenetic expression of EGR-1 during exposure to novelty. 
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Figure 4 : APP controls EGR-1 expression in vivo.  
A) EGR-1mRNA levels were quantified by q-RT PCR in mouse cortex (n=9 mice per group). Values were 
normalized to the GAPDH mRNA, and expressed as percentage of the APP+/+ tissue. Student’s t-test:      
***p < 0.001. B) EGR-1 protein expression was detected by Western blot analysis of extracts obtained from 
cortex of APP +/+ and APP -/- mice, 5 months of age (n=5). Typical blot is shown with anti-tubulin utilized as 
a loading control. EGR-1/tubulin ratio were quantified, and expressed as percentage of the APP+/+ mice. 
Student’s t-test : ***p<0.001 . Data are expressed as mean ± SEM.C) Chromatin immunoprecipitations of 
EGR-1 promoter were performed on chromatin isolated from mice cerebral cortex (n=7) with normal IgG as 
negative control, anti-acetylated H3 antibody, or anti-acetylated H4 antibody. Immunoprecipitated DNA was 
quantified by qPCR and normalized to the input. Two way Anova, n.s. non-significant, *p<0.05 
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Figure 5: APP is needed to induce EGR-1 by novelty. 
A) EGR-1mRNA levels were quantified by q-RT PCR in cortex of APP+/+ and APP-/- mouse 
exposed (OF) or not (not stimulated: NS) to the open field during 15 min (n=10). Values were 
normalized to the GAPDH mRNA, and expressed as percentage of the APP+/+ NS. One way 
Anova (***p<0.001) B) Chromatin immunoprecipitations of EGR-1 promoter were performed on 
chromatin isolated from cerebral cortex APP +/+ and APP -/- mice exposed or not to novelty 
(n=7 per group) with normal IgG as negative control and anti-acetylated H4 antibody. 
Immunoprecipitated DNA was quantified by qPCR and normalized to the input. Two way Anova, 
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Up regulation of EGR-1 in brain of patients with Alzheimer disease. 
EGR-1 was previously described to be up regulated in brain of AD patients [14, 20, 21]. Since our 
results indicate that APP epigenetically down regulates EGR-1 gene transcription, we wondered 
whether up regulation of EGR-1 in AD could be related to down regulation of APP. Control and AD 
brains were analyzed in western blotting using anti-EGR-1 and anti-APP antibodies. Results 
presented in figure 6 confirm up regulation of EGR-1 in AD brains. However, a concomitant 
significant decrease in APP was not observed. These results suggest that up regulation of EGR-1 in 
AD is APP independent, or that a particular function of APP is lost in AD, resulting in up regulation 
of EGR-1 expression similar to that found in APP knockout mice.   
 
 
 
 
 
 
 
 
 
 
 
Figure 6: EGR-1 is up-regulated in Alzheimer’s disease  
Egr-1 and APP protein levels were measured in AD (n=3) versus control (n=3) brains by Western 
blotting. Analyses were performed on total lysates of temporal cortex. Egr-1 was detected with 
sc-110 antibody, APP with anti-APP C terminal (HM) and anti-tubulin was utilized as a loading 
control. 
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E. Discussion 
Our findings demonstrate that both in cultured neurons and in vivo, APP is able to significantly 
down regulate EGR-1 expression. In both non amyloidogenic and amyloidogenic catabolic 
pathways, APP is cleaved by the γ-secretase activity to release the APP intracellular domain (AICD), 
which is able to regulate transcription of several genes, including APP itself, the GSK3β, and the 
Aβ-degrading enzyme neprilysin  [3,4,22,23,6,24,25]. It has been however established that nuclear 
location of AICD and consequent transcriptional regulation is dependent on APP processing 
through the amyloidogenic pathway [25,26,27]. Although regulation of gene transcription by AICD 
has been a matter of debate [28,29], probably reflecting the cell specificity of AICD regulation 
[30,31,32], it has been demonstrated by chromatin immunoprecipitation studies that AICD does 
interact with promoter regions of putatively regulated genes [24,25]. Here, we have demonstrated 
that the cleavage of APP by the γ-secretase activity to release AICD is not necessary for APP-
mediated regulation of EGR-1 expression, and that AICD does not interact with the EGR-1 
promoter in chromatin immunoprecipitation studies. APP mediates epigenetic control of a number 
of genes, including the AQP1 gene [8], at least in part through displacement of histone 
deacetylases (HDAC) [24]. In agreement with these data, we demonstrate here an enrichment of 
acetylated H4 on the EGR-1 promoter, both in APP-/- cultured neurons and in APP-/- mouse brain, 
arguing for the epigenetic control of EGR-1 expression by APP. Acetylation of H4, in particular at 
position K12, has been previously reported to increase transcription of memory related genes and 
mice unable to induce acetylation of H4K12 show learning and memory impairments [33]. Our 
preliminary results indicate that acetylated H4K12 is enriched on the EGR-1 promoter in absence 
of APP. Acetylation of H4 at position K12 is highly regulated by HDAC2 activity [18]. Whether APP 
affects expression or cellular localization of HDAC2 deserves further investigations. 
In some cases, other APP metabolites, and in particular soluble APPs, are also able to control gene 
expression [34].  Recently, secreted β- and α-APP were reported to induce axon outgrowth in vitro 
through EGR-1 signaling [35]. In this study, bacterial recombinant sAPPα or sAPPβ added to 
primary neuronal cultures were able to stimulate EGR-1 expression. In our study, the culture 
medium recovered from APP+/+ neurons was not able to modify EGR-1 expression in APP -/- 
neurons (data not shown).  
Induction of EGR-1 is required in the hippocampus and in the cortex for the formation of memory 
and late long term potentiation [9]. In mouse brain, EGR-1 is induced following 15 minutes 
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exposure to novelty in an open field [36].  Accordingly, we were able to induce EGR-1 expression in 
brain of APP+/+ mice during a 15 min exposure to novelty, and this induction was concomitant 
with enrichment of acetylated H4 at the EGR-1 promoter. In marked contrast with APP+/+ mice, 
APP-/- mice were unable to induce EGR-1 expression during exposure to novelty, readily explained 
by the high basal level of EGR1 expression in these mice. APP could therefore play a major role as 
an epigenetic regulator of transcription of genes involved in memory formation. EGR-1 up 
regulation in both AD and APP knockout mice could result from a loss of particular function of APP 
in AD, related to memory formation.  
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In the second part of my work, we tried to figure out whether expression of other IEGs is under 
APP regulation, and in particular, which are the epigenetic mechanisms underlying this regulation? 
First, we decided to assess the level of expression of IEGs sharing many features of transcriptional 
regulation with Egr-1 and involved in neuronal activity. Among the list of IEGs studied, three of 
them (c-Fos, Bdnf and Arc) showed decreased mRNA levels in APP-/- prefrontal cortex.   
As for Egr-1, we assessed the global acetylation of histones H3, H4 and H2B surrounding the 
promoters of the genes, and we observed an increase of H4 acetylation at the promoter of c-Fos 
and BDNF but not ARC in APP-/- mice. Those results suggested the same kind of regulation by APP.  
In order to establish the epigenetic partners of APP involved in this regulation, we focus our 
research on the positions acetylated on H4, as acetylation of specific lysines are performed by 
specific HAT.  
Basing our research on the literature explaining the epigenetic regulation of IEGs and the 
epigenetic partners of APP, we then assessed the recruitment of histones modifiers at the 
promoter of c-Fos and Egr-1. 
This led us to divergent observations: 
a. APP dependent regulation of Egr-1 regulation do not occur via Tip60 recruitments, 
but by the differential enrichment of CREB on its promoter in APP-/- mice 
b. APP dependent regulation C-Fos is based on the greater enrichment of HDAC2 on 
c-Fos promoter in APP+/+ mice 
Finally, we extended the observation made in the first publication about the induction of IEGs 
upon exposure to novelty, by showing that c-Fos expression was not significantly increased in APP-
/- mice after exposition to novelty. 
These results are in press and presented in the next pages. 
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II. Epigenetic	Regulations	of	Immediate	Early	
Genes	Expression	Involved	in	Memory	
Formation	by	the	Amyloid	Precursor	Protein	of	
Alzheimer	Disease.	
 
Hendrickx Aurélie, Pierrot Nathalie, Tasiaux Bernadette, Schakman Olivier, Kienlen-
Campard Pascal, De Smet Charles & Octave Jean-Noël.   
PLOS ONE | June 2014 | Volume 9 | Issue 6 | e99467 
A. Abstract	
We previously demonstrated that APP epigenetically regulates Egr1 expression both in cultured 
neurons and in vivo. Since Egr1 is an immediate early gene involved in memory formation, we 
wondered whether other early genes involved in memory were regulated by APP and we studied 
molecular mechanisms involved. By comparing prefrontal (PF) cortex from wild type (APP+/+) and 
APP knockout mice (APP-/-), we observed that APP down regulates expression of four immediate 
early genes, Egr1, c-Fos, Bdnf and Arc. Down regulation of Egr1, c-Fos and Bdnf transcription 
resulted from a decreased enrichment of acetylated histone H4 on the corresponding gene 
promoter. Further characterization of H4 acetylation at Egr1 and c-Fos promoters revealed 
increased acetylation of H4K5 and H4K12 residues in APP -/- mice. Whereas APP affected Egr1 
promoter activity by reducing access of the CREB transcription factor, its effect on c-Fos appeared 
to depend on increased recruitment of HDAC2 histone deacetylase to the gene promoter. The 
physiological relevance of the epigenetic regulation of Egr1 and c-Fos gene transcription by APP 
was further analyzed following exposure of mice to novelty. Although transcription of Egr1 and c-
Fos was increased following exposure of APP +/+ mice to novelty, such an induction was not 
possible in APP-/- mice with a high basal level of expression of these immediate early genes.  
Altogether, these results demonstrate that APP-mediated regulation of c-Fos and Egr1 by different 
epigenetic mechanisms is needed for their induction during exposure to novelty.  
B. Introduction	
One of the first steps involved in memory formation is the rapid induction of immediate early 
genes (IEGs) transcription in the brain. Egr1 is an IEGs member of early growth response family of 
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zinc fingers transcription factors, widely studied for its role in reconsolidation of memory and its 
ability to establish long term spatial localization memories [1,2].  In mouse, Egr1 is needed for late-
phase LTP, is involved in long-term memory formation and controls neuronal function in the 
hippocampus [3, 4].  
Expression of c-Fos protein in neurons is induced by a wide range of sensory stimuli [5,6] and 
several studies have demonstrated the role of c-Fos in the establishment of neuronal plasticity by 
regulating downstream gene expression [7,8]. c-Fos deficient animals show spatial and associative 
learning deficits correlated with decrease in synaptic plasticity [9]. Although expressed at low 
levels in the brain, transcription of c-Fos gene sharply increases after exposure to novelty. Both 
Egr1 and c-Fos mRNA levels are significantly increased 30-45 minutes after exposure to novelty, in 
particular in the CA1 and CA3 regions of the hippocampus as well as in the PF cortex [10].  
Contrary to Egr1 and c-Fos, Arc protein is not a transcription factor but an effector synaptic 
protein involved in multiple neuronal pathways [11]. Arc induction occurs in the hippocampus and 
the cortex following exploration of a novel environment [12]. LTP and synaptic activation also 
induce Arc expression both at the mRNA and protein levels [13].  
Bdnf is a member of neurotrophin family involved in neuronal growth and survival [14], in the 
development of dendritic network modulating synaptic transmission [15] and in the regulation of 
synaptic plasticity and memory formation [16]. In rodents, at least 22 different Bdnf mRNA are 
produced by alternative splicing of a primary transcript, and 9 alternative promoters control Bdnf 
gene transcription, but exon IV promoter is preferentially induced by neuronal activity [17, 18]. 
Chromatin remodeling also controls Bdnf gene transcription in neurons [19]. 
We previously demonstrated that the amyloid precursor protein (APP) of Alzheimer disease 
regulates, at the epigenetic level, the transcription of the Egr1 gene [20]. Induction of IEGs 
expression is closely related to a final change in chromatin remodeling that allows gene expression 
[21]. Recruitment of CREB on the Egr1 and c-Fos gene promoters induces an increase in histones 
acetylation mediated by the CBP/P300 acetyltransferase, and the concomitant depletion of HDACs 
[19].  
Here we show for the first time that APP fosters a low level of Egr1 and c-Fos expression in mouse 
PF cortex, by inhibiting CREB recruitment and improving HDAC2 recruitment on the corresponding 
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gene promoters. A low constitutive level of Egr1 and c-Fos expression mediated by APP is needed 
for their induction during exposure of mice to novelty.  
C. Material and Methods 
Animals 
Five months old mice C57Bl/6J APP+/+ and APP -/- were used in this study. Mice were obtained 
from The Jackson laboratory and backcrossed for more than five generations in the CD1 genetic 
background. All animals had access to food ad libidum and were housed under controlled 
temperature (22°C) and with a 12h light cycle (starting at 7 am).  One week before experiments, 
mice were moved to the experimental platform. As previously described, the behavioral test of 
exposure to novelty was performed in a square openfield (60x60x40cm) with gray plastic walls. 
Mice were able to explore this environment during 15 minutes and sacrificed by CO2 inhalation 
after a resting period of 30 minutes. Another group of mice were directly sacrificed without 
exposure to the open field. After brain dissection, PF cortex and hippocampus were directly placed 
in liquid nitrogen, frozen at -80°C or directly crushed and used in further experiments. All 
manipulations on mice have been approved by the local ethics committee of the catholic 
University of Louvain and follow the European legislation. 
RNA extraction and quantitative real time PCR 
 
Total RNA was purified using Trizol method (Tripure, Roche). Reverse transcription (RT) and 
quantitative (q) real time PCR (q-RT PCR) were performed with the iScript cDNA synthesis Kit and 
the iQ SYBR Green supermix using a iCycler MyIQ2 multicolor Real-Time PCR detection system 
(Biorad). The relative amplification of cDNA fragments was calculated by the 2-ΔΔCt method. q-RT 
PCR primer sequences used were as follows: Egr1 Forward: TCCTCTCCATCACATGCCTG, Egr1 
Reverse: CACTCTGACACATGCTCCAG, c-Fos Forward: GATGTTCTCGGGTTTCAACG, c-Fos Reverse: 
GGAGAAGGAGTCGGCTGG. GAPDH Forward: ACCCAGAAGACTGTGGATGG, GAPDH 
Reverse: ACACATTGGGGGTAGGAACA, Arc Forward: GCTGAGCTCTGCTCTTCTTCA, Arc Reverse: 
GGTGAGCTGAAGCCACAAAT Bdnf Forward: GCGGACCCATGGGACTCT, Bdnf Reverse: 
CTGCTGCTGTAGTGACCGA. 
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Chromatin immunoprecipitation (ChIP) 
ChIP was performed using the EZ-ChIP Assay kit (Millipore) according to manufacturer instructions 
and as described previously [20]. Chromatin was isolated and pooled from the two PF cortices of a 
single mouse. ChIP experiments were performed using a minimum of 3 mice per group. Chromatin 
was sheared in an ice bath by a 25 cycles of 30 sec on/off sonication using the “Bioruptor® UCD-
20’” sonicator (Diagenode). Samples were kept on ice during 30 s between two pulses. An aliquot 
of precleared chromatin was collected as the input. The samples were incubated overnight at 4°C 
with the antibodies of interest: 5µg anti-H4Ac (Millipore), 5µg anti-H3Ac (Millipore), 5µl anti-
H2BAc (Abcam); 10µl anti-Tip60 (SantaCruz), 5µl anti-HDAC2 (Abcam), 10µl anti-CREB total 
(Millipore), 3µl of acetylated H4K5, K12, K16 (Active Motif). The immunoprecipitated chromatin 
was analyzed by quantitative PCR with primers designed to amplify short regions of the promoters 
of genes of interest. 
qPCR primers were as follows: Egr1 Forward: GTGCCCACCACTCTTGGAT, Egr1 Reverse: 
CGAATCGGCCTCTATTTCAA, c-Fos  Forward : GAAAGCCTGGGGCGTAGAGT, c-Fos Reverse: 
CCTCAGCTGGCGCCTTTAT, Arc  Forward :  CAGCATAAATAGCCGCTGGT , Arc Reverse: 
AGTGTGGCAGGCTCGTC, Bdnf exIV Forward: GCGCGGAATTCTGATTCTGGTAAT, Bdnf exIV Reverse: 
GAGAGGGCTCCACGCTGCCTTGACG. GAPDH Forward: AGAGAGGGAGGAGGGGAAATG, GAPDH 
Reverse: AACAGGGAGGAGCAGAGAGCAC. The quantification method used is based on the ratio 
between immunoprecipitated chromatin and input chromatin.  
Protein analysis 
Nuclear extracts of mouse PF cortex were prepared in 0.25 M sucrose buffer (sucrose 0.25 M, Tris 
50mM, EDTA 1mM, imidazole 3mM, pH 7.0 + proteases inhibitor cocktail). Samples were 
centrifuged 10 min at 250 g and nuclear fraction was resuspended in Laemmli buffer.  All samples 
were sonicated before protein assay (BCA Pierce, Thermoscientific) and Western blotting was 
performed on 20 µg of protein lysates.  Membranes were incubated overnight at 4°C with the 
primary antibodies; anti-HDAC2 1:1500 (Abcam), anti-H3 1:10000 (Millipore), anti-tubulin 1:4000 
(Sigma), anti-CREB and phospho-CREB 1:1000 (Millipore). Washes with PBS-Tween (0.005%) were 
followed by incubation with secondary antibody (1:10 000 anti-mouse or anti-rabbit IgG) (GE 
Healthcare) coupled to horseradish peroxidase and revealed by ECL. For quantification, the 
membranes were stripped and reincubated with an anti-tubulin or an anti-H3 antibody. 
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Immunoreactive bands were quantified with an electrophoresis Gel Doc 2000 imaging system 
coupled to a Quantity one™ software (Bio-Rad).   
Statistical analysis 
All results were expressed as mean ± standard deviation (SD) values. Statistical significance was 
determined by student’s t-test for two-group comparisons or one-way analysis of variance 
(ANOVA) followed by Bonferroni’s multiple comparisons test for multi-group comparison. 
D. Results 
APP decreases the transcription of 4 different IEGs in the mouse PF cortex 
RNA was prepared from the hippocampus and PF cortex of APP+/+ and APP-/- mice, and qRT-PCR 
were performed to quantify IEGs mRNAs. Results presented in figure 1A indicate a 2.5 increase in 
Egr1 mRNA levels in PF cortex of APP-/- mice, confirming our previous results [20]. We wondered 
whether transcription of other IEGs involved in memory formation could also be regulated by APP. 
Results presented figure 1B indicate a significant increase in c-Fos, Arc and Bdnf mRNA levels in 
APP-/- mice. Levels of IEGs mRNA were normalized to GAPDH mRNA levels, which were not 
regulated by APP, as 3 other housekeeping genes (Actin, peptidylprolyl isomerase A, and β-
glucuronidase) (supporting information 1). In addition, expression of 2 other IEGs (c-Jun and 
Homer-1a) was not affected by APP (supporting information 1).   
These results therefore suggest that APP is able to regulate transcription of several IEGs involved 
in memory formation.  
APP affects enrichment of acetylated histone H4 on genes promoters 
We previously observed that the control of Egr1 gene transcription by APP is independent of the 
APP intracellular domain (AICD) but occurs at the epigenetic level [20]. Therefore, we wondered 
whether APP could control transcription of other IEGs by the same mechanism. To that aim, ChIP 
experiments were performed using anti-acetylated histones antibodies. Results presented in figure 
2A clearly demonstrated a specific enrichment of acetylated H4, but not H3 and H2B, on the Egr1 
promoter in APP-/- mice, confirming our previous results [20]. Interestingly, the same specific 
enrichment of acetylated H4 was measured on both the c-Fos (Figure 2B) and Bdnf (Figure 2C) 
gene promoters in APP-/- mice. No modification in H3Ac, H2BAc and H4Ac enrichment on the 
GAPDH gene promoter was observed in APP+/+ and APP-/- experimental conditions (supporting 
information 2). Enrichment of acetylated H4 was not observed on the Arc gene promoter in APP-/- 
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mice (Figure 2D), indicating that a different molecular mechanism is involved in the APP-mediated 
regulation of Arc gene expression. This conclusion, together with a much weaker up regulation of 
Bdnf expression in APP-/- mice (Figure 1) led us to focus on the molecular mechanisms involved in 
the regulation of Egr1 and c-Fos expression by APP.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1  : APP regulates IEGs expression in mouse PF cortex  
A) Egr1 mRNA levels were quantified by q-RT PCR in APP+/+ and APP-/- PF cortex (n=9), and in 
the hippocampus (n=6). B) q-RT PCR method was used to quantify mRNA levels of c-Fos, Arc 
and Bdnf in APP+/+ and APP-/- PF cortex (n=6).   Values were normalized to the GAPDH mRNA, 
and expressed as percentage of APP+/+, mean ± SD. Student’s t-test : ***p<0.001 ,**p<0.01, 
*p<0.05.  
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Figure 2:  Analysis of histone acetylation by ChIP assays on IEGs promoters  
ChIP experiments were performed with chromatin obtained from APP+/+ and APP-/- PF cortex. 
Immunoprecipitation was completed with antibody recognizing normal mouse IgG as negative control, 
or anti- H3Ac, H2BAc and H4Ac antibodies. The quantification of immunoprecipitated chromatin and 
the normalization versus total chromatin (input) was assessed by real-time qPCR with primers 
designed on A) Egr1, B) c-Fos, C) Arc and D) Bdnf exon IV promoters; *p<0.05. All results were obtained 
from at least 3 mice per group and per antibody, and are expressed as mean ± SD.  
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APP specifically regulates acetylation of histone H4 at lysines 5 and 12.  
Acetylation of histone H4 can occur at different positions including lysines 5, 12 and 16. To identify 
the positions that are acetylated on H4 enriched on the Egr1 and c-Fos gene promoters in APP-/- 
mice, ChIP experiments were performed using anti-H4K5Ac, -H4K12Ac and -H4K16Ac specific 
antibodies. Results presented in figure 3A indicate that histones H4 enriched on the Egr1 gene 
promoter in APP-/- mice were acetylated on positions K5 and K12, but not on K16. Interestingly, 
the same profile of acetylation was found for histone H4 enriched on the c-Fos gene promoter in 
APP-/-mice (Figure 3B). These results suggest that APP regulates Egr1 and c-Fos gene transcription 
by similar molecular mechanisms. 
 
 
 
 
 
 
 
 
 
 
Figure 3: H4K5 and H4K12 are enriched at Egr1 and c-Fos gene promoter in APP-/-  mice 
ChIP method was used to evaluate the enrichment of H4K12Ac, H4K5Ac, and H4K16Ac. A) Egr1 
promoter. B) c-Fos promoter. Data represent the level of enrichment normalized as percentage of 
APP+/+. *** p<0.001. All results derive from at least 3 mice per group and per antibody, and are 
expressed as mean ± SD.  
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Regulation of Egr1 gene transcription by APP is CREB dependent 
A schematic representation of the Egr1 gene promoter is given in figure 4A [22]. The histone 
acetyltransferase Tip60 is able to acetylate histone H4 at positions H4K5 and H4K12 [23] and 
interacts with AICD [24]. Therefore, an interaction between Tip60 and APP could inhibit H4K5 and 
H4K12 acetylation in APP+/+ mice. To test this hypothesis, ChIP experiments were performed 
using anti-Tip60 antibodies. Tip60 is able to bind to the promoter of KAI1 gene and regulates its 
transcription [25,26]. In Chip experiments, we indeed demonstrated an enrichment of Tip60 on 
the promoter of the KAI1 gene (supporting information 3). However, results presented in figure 4B 
do not show any enrichment of Tip60 on the Egr1 gene promoter in APP-/- mice, allowing us to 
rule out the implication of Tip60 in this regulation. On the other hand, acetylation of H4K5 and 
H4K12 is mediated by CBP/P300, which associates with phosphorylated CREB DNA binding protein 
[27]. In addition, the Egr1 promoter contains two CREB responsive elements (CRE) (Figure 4A). 
Therefore we attempted to immunoprecipitate CREB on Egr1 promoter and we confirmed that 
this transcription factor was significantly more enriched on the Egr1 gene promoter in APP -/- mice 
(figure 4C).  To test whether APP was able to down regulate CREB expression or to inhibit its 
phosphorylation, nuclear extracts from APP+/+ and APP-/- mice were analyzed in Western blotting 
using anti-CREB and anti-S133PhosphoCREB specific antibodies. Results presented in figure 4D 
indicate the same CREB/PhosphoCREB ratio in APP+/+ and APP-/- mice, ruling out modification of 
CREB expression and phosphorylation by APP. The recruitment of CREB on a gene promoter is 
often followed by local depletion of several HDACs [28,29]. As HDAC2 epigenetically regulates 
transcription of several IEGs including Egr1 [30], we also performed ChIP experiments using 
HDAC2 antibodies. Results presented in figure 4E do not show any significant enrichment of 
HDAC2 on the Egr1 gene promoter in APP-/- mice.  Altogether, these results indicate that APP 
fosters low level of Egr1 expression in mouse brain by inhibiting recruitment of CREB without 
affecting enrichment of HDAC2 on the Egr1 gene promoter.  
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Figure 4: CREB is better recruited on the Egr1 gene promoter in APP-/- mice 
A) Schematic representation of the structure of Egr1 gene promoter containing several binding sites for 
transcription factors and localization of primers utilized for q-PCR (CREB: cAMP response element, CRE: 
cAMP response elements SRF: Serum Response factor, SRE: Serum Response Element, SP1 : specificity 
protein).  B) Tip60 binding to Egr1 gene promoter in APP+/+ and APP-/- PF cortex was assessed by ChIP 
using anti-Tip60 antibody. C) CREB binding to Egr1 promoter in APP+/ and APP -/- mice. IgG was used as 
negative control. Equal amounts of ChIP and input DNA were used for qRT-PCR analysis on the Egr1 gene 
promoter. Results show a significantly lower enrichment of CREB in APP +/+ mice, * p<0.05. Enrichment 
values were normalized to input values and represented the average of three or more experiments per 
group. Results are expressed as mean ± SD. D) Ratio between total and phosphorylated CREB was 
detected by western blot analysis of nuclear extracts from PF cortex of APP +/+ and APP -/- mice, 5 
months of age (n=5). Typical blot is shown, CREB/P-CREB ratio were quantified, and expressed as 
percentage of the APP+/+ mice. Data are expressed as mean ± SD. E) ChIP assay on Egr1 promoter using 
HDAC2 antibody.  
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Regulation of c-Fos gene transcription by APP is HDAC2 dependent 
The c-Fos gene promoter also contains a single CRE site (Figure 5A). The same profile of 
acetylation of histone H4 enriched on c-Fos and Egr1 gene promoters in APP-/-mice (Figure 3B) 
suggested that APP might regulate Egr1 and c-Fos gene transcription by similar molecular 
mechanisms. Therefore, we first measured recruitment of CREB on the c-Fos gene promoter in 
APP+/+ and APP-/- mice. Results of ChIP experiments (Figure 5B) show an enrichment of CREB on 
c-Fos promoter, but no difference between APP+/+ and APP-/- mice, suggesting that basal 
regulation of c-Fos gene transcription by APP is not CREB dependent although c-Fos is regulated by 
CREB [31]. Since HDAC2 was previously demonstrated to inhibit c-Fos gene transcription [30], we 
performed ChIP experiments using anti-HDAC2 antibodies. Results presented in figure 5C clearly 
indicate a significant enrichment of HDAC2 on the c-Fos gene promoter in APP+/+ mice. Western 
blot analysis of nuclear extracts prepared from the PF cortex of APP+/+ and APP-/- mice with anti-
HDAC2 antibodies did not show any modification of HDAC2 nuclear or cytoplasmic content, 
indicating that APP does not modify neither HDAC2 expression nor its nuclear localization (Figure 
5D).  Altogether, these results indicate that APP fosters a low level of c-Fos expression in mouse 
brain by increasing enrichment of HDAC2 on the c-Fos gene promoter.  
 
 
 
 
 
 
 
 
 
 
  Results 
100 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5: HDAC2 is enriched on the c-Fos gene promoter in APP-/- mice 
A) Schematic representation of the structure of c-Fos promoter containing only one CREB binding 
site and the localization of the primers utilized for q-PCR. (CREB: cAMP response element, CRE: 
cAMP response elements SRF: Serum Response factor, SRE: Serum Response Element,  AP1: 
Activator protein 1, SIE : serum-inducible element, STAT: Signal Transducer and Activator of 
Transcription).  B) Study of CREB binding to c-Fos gene promoter in APP+/ and APP -/- mice. C) ChIP 
assay on c-Fos gene promoter using anti-HDAC2 antibody. Results show a significant lower 
enrichment of HDAC 2 in PF cortex of APP-/- mouse, Student’s t-test : **p<0.01. IgG was used as 
negative control. Equal amounts of ChIP and input chromatin were used for qRT-PCR analysis on 
the c-Fos gene promoter. Enrichment values were normalized to input values and represented the 
average of three or more mice per experiment. Results are expressed as mean ± SD. D) HDAC2 
protein expression was detected by western blot analysis of nuclear (N) or cytoplasmic (C) extracts 
obtained from PF cortex of APP +/+ and APP -/- mice, 5 months of age (n=5). Typical blot is shown 
with anti-histone H3 and anti-tubulin used as a loading control. Data are normalized against 
histone H3 to assess the level of nuclear HDAC2 and expressed as mean ± SD. 
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Exposure of mice to novelty induces IEGs transcription in APP +/+ but not in       
APP-/- mice. 
Egr1 and c-Fos are inducible transcription factors that are needed for synaptic plasticity and 
establishment of long term memory. We reasoned that induction of IEGs transcription needs a 
constitutive low level of expression, as measured for Egr1 and c-Fos in APP+/+ mice. APP+/+ and 
APP-/- mice were exposed to novelty during a spatial exploration of an open field, in an 
experimental protocol that was previously described to enhance c-Fos and Egr1 mRNA levels in 
mouse PF cortex [10,32]. After a short period of exploration of 15 min and a resting period of 30 
min, the mRNA levels of IEGs were quantified in APP +/+ and APP -/- mice. Results presented in 
figure 6 clearly demonstrated that induction of both Egr1 and c-Fos gene transcription was 
possible in APP+/+ but not in APP-/- mice. These results suggest that the low level of IEGs 
transcripts measured in APP+/+ allow their induction during exposure of mice to novelty, while 
such an induction is not possible in APP-/- mice showing a high basal level of IEGs expression.  
 
 
 
 
 
 
 
 
 
Figure 6: APP+/+ but not APP -/- mice induce Egr1 and c-Fos expression after exposure to 
novelty  
A) Effect of exposure to novelty on the levels of Egr1 and c-Fos transcripts. qRT PCR were 
performed on mRNA extracted from APP +/+ and APP -/- mice exposed (Novelty) or not (Home 
cage) to the open field (n=6 or more per group).  All values were normalized to the GAPDH mRNA, 
and expressed as percentage of the APP+/+. Results are expressed as mean ± SD. Student’s t-test. 
(***p<0.001)  
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E. Discussion 
The main finding of this study is that APP fosters low expression of c-Fos and Egr1 in mouse PF 
cortex, in which induction of several IEGs is involved in memory formation [33-35]. APP-mediated 
down regulation of c-Fos and Egr1 by two distinct epigenetic mechanisms is needed to induce 
properly transcription of these IEGs upon exposure of mice to novelty.  
We extended our observation of the epigenetic regulation of Egr1 gene transcription by APP to c-
Fos, Bdnf and Arc.  All of those genes belong to the IEGs family of transcription or neurotrophic 
factors needed for memory formation [2, 7, 36, 37]. The ability of APP to increase gene 
transcription by an AICD dependent mechanism has been previously demonstrated, although still 
debated [38-43].  
Induction of IEGs through acetylation of histones H3, H4 and H2B is well documented [44], and 
acetylation of histone H3K14, H4K12 or phosphorylation of H3S10 via ERK activation are 
associated with chromatin relaxation leading to IEGs transcription and memory formation [45-47]. 
We have previously demonstrated that trichostatin A, a specific HDAC inhibitor, was able to induce 
Egr1 gene transcription in both APP+/+ and APP-/- neurons, although induction was significantly 
higher in APP-/- neurons, in agreement with higher H4 acetylation at the Egr1 gene promoter in 
these cells [20].  
Although induction of IEGs has been widely studied, little is known about basal regulation of IEGs 
transcription in the hippocampus and the cortex. Basal expression of IEGs in the brain is referred 
as an expression induced by physiological synaptic input [48]. We demonstrate here that APP 
fosters a low level of expression of the four IEGs studied. APP represses transcription of Egr1, c-
Fos, and Bdnf by decreasing enrichment of acetylated H4, but not H3 nor H2B histones on the 
corresponding gene promoters. APP-mediated repression of Arc gene transcription appears to be 
controlled by other molecular mechanisms. SAHA, a nonspecific HDAC inhibitor, was 
demonstrated to up regulate c-Fos and Bdnf expression, while Arc induction was much more 
moderate [49], indicating that Arc expression should be regulated by other mechanisms than 
histone modification.  
We observed a very similar acetylation profile of H4K5 and H4K12, but not H4K16, on Egr1 and c-
Fos gene promoters, which suggested that APP might regulate both genes by similar mechanisms. 
H4K5 and H4K12 are known to be acetylated by Tip60 and CBP/P300 histone acetyltransferase 
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activities [23]. As Tip60 interacts with AICD and the adaptor protein Fe65 [24], APP could inhibit 
H4K5 and H4K12 acetylation in APP+/+ mice. We analyzed a possible interaction of Tip60 with Egr1 
promoter but failed to detect any significant interaction or any enrichment in APP-/- mice. 
Therefore, the contribution of CBP/P300 in the acetylation of H4K5 and H4K12 present on the Egr1 
and c-Fos gene promoters was further investigated.  
CBP and p300 are two highly related histone acetyltransferases that share many biological 
functions and interact with phosphorylated cAMP response element binding protein (CREB) [50]. 
CRE sites are present on Egr1 and c-Fos gene promoters, and regulation of Egr1 and c-Fos gene 
transcription by CREB is well established [19,21,31,51]. We demonstrate that regulation of Egr1 
gene transcription by APP is CREB dependent. In APP-/- mice, CREB is better recruited on the Egr1 
gene promoter, arguing for a CBP/P300-mediated increase in H4K5 and H4K12 acetylation of H4 
present on the Egr1 promoter. The presence of CREB on a gene promoter has been associated 
with the removal of HDACs [28].  HDAC2 deacetylates H4K5 and H4K12, and is described as a 
negative actor in memory formation and synaptic plasticity [30]. Even if we were able to detect 
enrichment of HDAC2 on Egr1 gene promoter, the level of HDAC2 detected was the same in 
APP+/+ and APP-/- mice.  
Surprisingly, regulation of c-Fos gene transcription by APP occurs by a different mechanism, since 
the same recruitment of CREB on the c-Fos gene promoter was measured in both APP+/+ and APP-
/- mice but less HDAC2 was found on the c-Fos gene promoter in APP-/- mice. APP decreased CREB 
recruitment on Egr1 gene promoter and increased HDAC2 recruitment on c-Fos gene promoter, 
without any modification of either CREB and HDAC2 expression or CREB phosphorylation. The 
presence of two CRE sites in the Egr1 gene promoter could explain why APP-mediated regulation 
of this gene is more dependent on CREB recruitment.  
Our results indicate that APP fosters a low expression of a group of IEGs involved in memory 
formation. Consequently, overexpression of APP could have important consequences on memory 
formation. Interestingly, it was previously demonstrated that in APP transgenic mice, 
overexpression of mutated APP decreases the basal levels of IEGs mRNA and impairs the proper 
induction of IEGs transcription upon exposure to novelty [32]. Similarities in the cognitive declines 
observed in both APP-/- and APP transgenic mice [52-54] could be related to their impairment in 
  Results 
104 
 
inducing properly IEGs transcription. Moreover, impairment of LTP observed in APP transgenic 
mice have been associated with dysregulation of histone H4 acetylation [55,56].   
Basal expression of IEGs is important for normal synaptic activity, but their rapid induction is 
needed to activate transcription of many genes playing a key role in establishment of long term 
memory [7]. An important function of APP is to epigenetically foster low level of expression of 
IEGs, allowing rapid induction of their transcription. 
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F. Supplemental figures 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S1 :  Housekeeping genes and other IEGs expressions are not regulated by APP 
GAPDH mRNA levels were quantified by q-RT PCR in APP+/+ and APP-/- PF cortex (n=6) and 
normalized versus Actin B) q-RT PCR method was used to assess mRNA levels of the housekeeping 
genes Actin, peptidylprolyl isomerase A (Ppia) and β-glucuronidase(Gusb) in APP+/+ and APP-/- PF 
cortex (n=6). C) mRNA levels of the IEGs c-Jun and Homer-1a were quantified by q-RT PCR in in 
APP+/+ and APP-/- PF cortex (n=6). Values were normalized to the GAPDH mRNA, and expressed as 
percentage of APP+/+, mean ± SD. Primers sequences used were as follows: Ppia FOR: 
CAGACGCCACTGTCGCTTT ; Ppia REV : TGTCTTTGGAACTTTGTCTGCAA, Gusb FOR: 
ACTGACACCTCCATGTATCCCAAG, Gusb REV: CAGTAGGTCACCAGCCCGATG, c-Jun FOR : 
TGAAAGCTGTGTCCCCTGTC ; c-Jun REV: ATCACAGCACATGCCACTTC, Homer 1a FOR: 
GAAGTCGCAGGAGAAGATG, Homer1a REV: TGATTGCTGAATTGAATGTGTACC. 
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Figure S2:  Analysis of histone acetylation by ChIP assays on GAPDH promoters  
ChIP experiments were performed on chromatin obtained from APP+/+ and APP-/- PF cortex. 
Immunoprecipitation was completed with antibody recognizing normal mouse IgG as negative control, 
anti H3Ac, H2BAc and H4Ac. The quantification of immunoprecipitated DNA and the normalization versus 
total DNA (input) was assessed by real-time qPCR with primers designed on GAPDH. All results were 
obtained from at least 3 or more mice per group and per antibody, and are expressed as mean ± SD.  
Figure S3:  Tip60 is enriched in KAI1 promoter  
Tip60 binding to KAI1 gene promoter in APP+/+ and APP-/- PF cortex was assessed by ChIP using anti-Tip60 
antibody, with primers designed in KAI1 promoter region. Primers sequences used were as follows: KAI1 FOR: 
ACCGTTAGGCAGCGCCGTGAG ; KAI1 Rev : CTTGGGAAGGCGGTGCGCTC. IgG was used as negative control. 
Results show a significant enrichment of Tip60 in APP +/+ mice, ** p<0.01. Enrichment values were 
normalized to input values and are the average of three or more experiments per group. Results are 
expressed as mean ± SD. 
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DISCUSSION		
A. Regulation of Egr-1 gene transcription by APP 
Throughout this work, we have demonstrated that APP -/- neurons show a higher basal expression 
of Egr-1 and that transcription of four IEGs is up-regulated in the prefrontal cortex of APP-/- mice. 
This suggests that APP has a repressive effect on these IEGs transcription. Down regulation of IEGs 
expression by APP is not deleterious and in the contrary is necessary to let neurons induce them 
properly upon stimulation.  
Even if we were able to depict in part the mechanisms involved in regulation of c-Fos and Egr-1 
occurring at genes promoters in the nucleus, the main question remains: which domain of APP is 
involved in this regulation?  
AICD dependent transcription  
According to the literature, AICD recruited on gene promoter is able to epigenetically regulate 
gene transcription and could have an activating or repressing effect on gene transcription 
depending on the target gene regulated: 
- Kajiwara et al. describe a model where the adaptor protein Fe65 recruits two proteins (SET 
and Teashirt) in a gene silencing complex able to recruit HDACs to inhibit the transcription 
of caspase 4 (Kajiwara et al., 2009).  
- In our laboratory, previous results showed association between AICD and HDACs resulting 
in the negative regulation of a transcriptional repressor that controls AQP1 gene 
expression in a second step (Huysseune et al., 2009).  
- In a study of Belyayev, presence of AICD on neprilysin gene promoter is associated with 
removal of HDAC1 and acetylation of histone H4 at positions K8 and K16 with a positive 
effect on gene transcription (Belyaev et al., 2009).  
- More recently, the team of Turner shows that transthyretin (TTR) is also epigenetically up-
regulated by AICD. The binding of AICD specifically on TTR gene promoter is able to 
displace HDAC1 and HDAC3 (Kerridge et al., 2014). 
In our experimental conditions, APP-mediated regulation of Egr-1 gene transcription seems to be 
independent of AICD. This conclusion emerged from the observation that Egr-1 expression was not 
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increased in APP+/+ neurons treated by the γsecretase inhibitor DAPT, as inhibition of the γ 
cleavage of APP impairs AICD production. We also investigated a possible interaction between 
AICD and the Egr-1 promoter in APP +/+ neurons, using ChIP experiments with two antibodies 
raised against the C-terminal domain of APP: a homemade antibody from N.Sergeant (Lille) and a 
commercial one (Sigma). Using these two different antibodies, we were unable to detect 
interaction between AICD and the Egr-1 promoter in Chip assays.  Altogether, these results argue 
for an AICD independent mechanism of APP-mediated regulation of Egr-1 gene transcription.   
Regulation of Egr-1 expression by APP soluble fragments 
Chasseigneaux et al. showed that soluble APPs are triggering Egr-1 expression, generating an 
increase in axon elongation (Chasseigneaux et al., 2011). In this study, bacterial recombinant 
sαAPP and sβAPP are added to primary culture of neurons at DIV1 at increasing concentrations 
from 50 to 150nM. At DIV5, the treatment is decreasing cell adhesion but increasing axon length 
together with Egr-1 expression.  Egr-1 knockout neurons are not responding anymore to APPs 
fragments, pointing out the determinant role of Egr-1 in this regulation.  
The differences in the way APP regulates Egr-1 expression, positively in the work of Chasseigneaux 
and negatively from our observations, could be explained by a concentration effect. Indeed, the 
concentrations of recombinant sαAPP and sβAPP used for their experiments are extremely high 
and do not reflect physiological conditions.  When we treated APP -/-neurons with APP+/+ culture 
medium containing soluble APP fragments, we did not observe a decrease in Egr-1 expression. 
Finally, the study shows that the MAPK inhibitor UO126 inhibits the effect of APPs fragments on 
axon elongation. This result suggests that Egr-1 induction happens through MAP kinase signaling 
cascade, giving us some indications about the transcriptional pathway that leads to Eg-1 induction.  
Effect of synthetic Aβ on Egr-1 expression 
Some studies show an effect of Aβ peptide on Egr-1 expression (Giri et al., 2004; Giri et al., 2005; 
Giri et al., 2003; Killick et al., 2014). In the study of Killick et al, administration of Aβ (3µM) on 
primary culture of rat neurons during a short period of time (3h) is followed by an induction of 2,5 
times of Eg-1 mRNA. According to them, Aβ treatment triggers Egr-1 expression via a complex 
molecular cascade requiring, among others, the c-Jun N-terminal kinase (JNK) (Killick et al., 2014). 
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In three other publications of the group of Kalra, Aβ treatment at a concentration of 125 nM up-
regulates expression of cytokines (in particular CCR5) by increasing the transcriptional activity of 
Egr-1 in THP-1 monocytic cells. It seems that Aβ could trigger activation of the MAPK pathway 
inducing Egr-1 expression which will in a second time regulate CCR5. The effect of Aβ is inhibited 
by Curcuma, suggesting a positive anti-inflammatory action of this substance (Giri et al., 2004; Giri 
et al., 2005; Giri et al., 2003) 
The different groups used quite different Aβ concentrations: really high ones in the work of Killick 
(3µM), and according to Giri et al, more physiological ones (125nM). On the contrary, in our study 
we detected Aβ in the cultured medium of APP+/+ neurons at a concentration of 500pg/ml, 
meaning a molar Aβ concentration of around 0.1nM. This is approximately 1000 times less than 
the “physiological condition” used by Giri et al. Consequently, Egr-1 induction observed in this 
study could result from a stress induced by toxic Aβ treatment of neurons, rather than by 
physiological Aβ secretion. 
Moreover, in our experimental conditions, a 50% decrease of Aβ concentration after DAPT 
treatment did not affect Egr-1 expression in APP+/+ neurons, suggesting that Aβ is not involved in 
the regulation of Egr-1 by APP. 
 Lessons from the rescue experiments 
In order to further investigate the implication of APP in the regulation of Egr-1 gene transcription, 
we studied whether a rescue of APP expression in APP-/- neurons led to a decrease in Egr-1 gene 
transcription. Therefore, we infected neurons with adenoviruses expressing either APP or APP 
deleted from its c-terminal domain (APP∆C). We faced two problems:  
APP-mediated regulation of Egr-1 gene transcription was observed between DIV3 and DIV5, and 
adenoviral expression in a so short period of time was not very efficient. 
Infection by adenoviruses, expressing APP or β galactosidase as negative control both induced Egr-
1 expression. The level of Egr-1 expression was actually proportional to virus load more than to the 
protein expressed.  
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Learning from APP -/- mouse model 
During my PhD, we used APP -/- mice in the CD1 genetic background to evaluate the role of APP 
on gene transcription regulation. Indeed APP knock-out animals are a good tool to evaluate the 
function of APP, by producing primary culture of neurons or by working with tissues coming from 
adult animals. The literature describing APP -/- mice is abundant and the phenotype associated to 
deletion of APP well described (see introduction). 
The idea of this part of the discussion is to cross-link the literature about APP -/- deficiency and the 
physiological function attributed to Egr-1 to try to link both together. It is obvious that the whole 
phenotype described in APP -/-mice is surely not only due to the differences we described in IEGs 
expression but it could, at least, give us some indications about the relevance of IEGs regulation by 
APP.  
First of all,  APP -/- phenotype includes  growth and brain weight deficits, reduced grip strength, 
agenesis of the corpus callosum, hypersensitivity to seizures, defects in copper and lipid 
homeostasis, altered locomotors activity, and impaired spatial learning associated with impaired 
long-term potentiation (Dawson et al., 1999; Grimm et al., 2007; Li et al., 1996; Magara et al., 
1999; Muller et al., 1994; Seabrook et al., 1999; Steinbach et al., 1998; Tremml et al., 1998; White 
et al., 1999; Zheng et al., 1995). Deficit in memory formation and hypersensitivity to seizures are 
interesting to discuss in relationship with Egr-1 functions.   
APP, Egr-1 and LTP 
In 1999, two studies described deficit of synaptic activity in aged APP -/- mice (Dawson et al., 
1999; Seabrook et al., 1999). Seabrook et al. showed that two groups of APP -/- mice at 8–12 
months, and 20–24 months of age showed impairment in the formation of long-term potentiation 
in the CA1 region compared to age matched controls. They associated those deficits of LTP with 
neuronal morphology and synaptic function within the hippocampus (Seabrook et al., 1999). On 
the other hand, Dawson described also an age dependent deficit in cognitive functions associated 
with a marked reactive gliosis in the cortex and hippocampus of APP -/- mice (Dawson et al., 
1999).  More recently, Ring et al. showed deficit in the rate of induction and maintenance of LTP in 
the CA3/CA1 pathway of hippocampus in APP -/- mice at old age. In order to understand which 
part of APP was involved in this regulation of synaptic plasticity, they established two models of 
Knock-In mice (KI) in APP -/- background. One was expressing sαAPP while the other one was 
expressing APP deleted from the 15 last amino acids corresponding to the YENPTY motif of AICD.  
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sαAPP rescued almost all the defects observed in APP -/- mice as brain weight and somatic growth, 
grip strength development, spontaneous home cage activity, exploratory activity, as well as spatial 
learning and finally LTP. Mice KI for APP lacking the last 15aa showed also normal LTP suggesting 
that LTP defects observed in APP -/- are not link to AICD function (Ring et al., 2007). 
In parallel, Egr-1 is strongly involved in the processes underlying memory formation. Indeed, Jones 
et al. show that Egr-1 KO mice exhibit impairments in late phase LTP and perform lowest in tests 
requiring long-term memory compared to WT.  Moreover, Egr-1 mRNA levels are increased during 
LTP events and during behavioral task involving among other spatial exploration and 
learning.(Cheval et al., 2012; Jones et al., 2001; Lee, 2008; Maddox et al., 2011; Yilmaz-Rastoder et 
al., 2011) . 
 Therefore, we suggest that the impairment of Egr-1 induction seen after exposition to novelty 
that we described in APP-/- mice prefrontal cortex could be detrimental in the LTP formation, and 
can lead to memory impairments and defect of LTP observed in APP-/- old mice.  
 However, the APP dependent regulation of IEGs that we described was observed in young mice 
(5moa) while memory deficits in those mice occur much later (from 8 to 24 moa).Then, it would be 
interesting to analyze Egr-1 expression in old mice, and assess how it is induced after stimulation, 
to clearly establish the relationship between induction of Egr-1 and memory deficits observed in 
aged APP-/-. Another hypothesis could be that Egr-1 overexpression observed in young APP -/- is a 
compensatory effect to avoid cognitive impairments that could be lost with ageing.  
We realize that LTP and memory processes are mostly studied in the hippocampus and further 
description of APP dependent IEGs expression needs also to be made in this region. The fact that 
we described a similar up-regulation of Egr-1 in both hippocampus and prefrontal cortex, is 
encouraging because it suggests the same kind of regulation of IEGs transcription in both cerebral 
structures, but we are aware that such comparison is not optimal and that further study of 
transcriptional events occurring in APP-/- hippocampus are required.  
APP, Egr-1 and hypersensitivity to seizures 
Another characteristic of APP -/- mice is their hypersensitivity to seizures.  
In one hand, seizures induced by intraperitoneal injection of kainic acid in mice are occurring 
earlier and with an increased frequency in APP-/- compared to APP +/+ mice. Seizures are also 
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followed by the induction of IEGs in the cortex and hippocampus of all mice, but c-Fos induction is 
greater in these regions of APP -/- mice (Steinbach et al., 1998). From our observations also, APP -
/- mice start epileptic seizures without any kind of stimulation suggesting a role of APP in the 
balance of neuronal activity.  As electroconvulsive seizures (ECS) are known to disrupt LTP in the 
neocortex and hippocampus  (Trepel and Racine, 1999), the high frequency of seizures observed in 
APP-/- could also be responsible for memory dysfunction and deficit in LTP observed in these mice.  
On the other hand, IEGs expression, and in particular Egr-1, c-Fos and Arc, is strongly up regulated 
after seizures induced by several types of stimulation (ECS , kainate treatment, pentylenetetrazole 
injection, tetanus toxin injection) in different brain regions (Calais et al., 2013; Liang and Jones, 
1997; Richardson et al., 1992; Szyndler et al., 2013; Taniura et al., 2006). In human epilepsy also, 
Egr-1 and c-Fos are a induced at epileptic foci and in cell lines coming from patients suffering 
epilepsy and compared to their healthy monozygotic twin  (Helbig et al., 2008; Rakhade et al., 
2007).  
At the molecular level, chromatin remodeling at IEGs promoter regions after seizures has been 
investigated by different groups. First, Huang described that drug-induced status epilepticus was 
followed by an increase in histone H4 acetylation at the BDNF gene promoter (Huang et al., 2002). 
Then, Tsankova et al. and others have demonstrated that ECS was followed by an increase of c-Fos 
and BDNF mRNA levels as well as an increase in H4 acetylation at genes promoters (Dyrvig et al., 
2014; Tsankova et al., 2004). These genes up-regulations imply only changes in the acetylation of 
histone H4, but not H3 (which seems still modified by phosphorylation) (Sng et al., 2006). It is 
remarkable because the regulation of IEGs expression by APP that we described is also merely 
related to changes in H4 acetylation levels.  
We must note that induction of IEGs occurs only in a short period of time after ECS and is followed 
by a long period of substantial decrease in IEGs expression (starting 24h after the last stimulus) 
(Calais et al., 2013; Tsankova et al., 2004) (Calais,Tsankova,2004). This is quite striking as our APP -
/- mice that show very common crisis show also a global increase in IEGs expression in basal state 
compared to APP+/+. This could be explained by the inability of APP-/- mice to induce properly 
IEGs expression or to “turn of” their expression after stimulation. For the time being, we don’t 
know if up-regulation of IEGs in APP-/-  PFC are a cause or a consequence of these seizures but 
further investigations in that direction would be of a great interest.  
  Discussion 
119 
 
Finaly, APP -/- mice show problems during the neuronal development in the retina. In the same 
time, Egr-1 is also involved in the development of the retina and Egr-1 KO mice show a relative 
axial myopia. Thus, APP dependent regulation of Egr-1 could have consequences in the neurons 
during the development of visual functions (Ho et al., 2012; Schippert et al., 2007; Sharma et al., 
2012) . 
B. Suggested mechanisms for APP-mediated regulation of gene 
transcription 
To understand how IEGs are regulated at the epigenetic level, it is important to know the cascade 
of events occurring upstream.  For this purpose, a short description of the signaling cascade 
leading to IEGs transcription will be presented first and is described in figure 19  
 Figure 19 Schematic representation of the signaling pathway leading to phosphorylation of CREB 
and ELK and inducing Egr-1 transcription (Tronson and Taylor, 2007) 
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After synaptic stimulation triggering the activation of NMDA/ AMPA/ kainate-type glutamate 
receptor, β adrenergic receptors or voltage-gated calcium channels, a Ca2+influx is produced at 
the postsynaptic neuron that is essential to convert synaptic activity into biochemical events 
leading to the induction of gene expression  (Bading et al., 1993; Lerea et al., 1992; Lerea and 
McNamara, 1993; Levenson et al., 2004).  This calcium entry is followed by the activation of many 
calcium regulated signaling enzymes, activating several signaling transduction cascades:  
- The calmodulin (CaM) pathway initiates upon binding to Ca2+, and leads to 
conformational switch of CaM enabling  the activation of a number of effector proteins in 
the cytoplasm and in the nucleus, including the Ca2+/CaM-dependent kinases II and IV 
(CaMKII and CaMIV), the ribosomal S6kinase (RSK)((Bading et al., 1993; Cortés-Mendoza et 
al., 2013; Flavell and Greenberg, 2008). This lead to CREB phosphorylation and Egr-1 
activation 
- cyclic AMP activates the PKA  and the acts through the Ras/Raf and MEK pathway that will 
lead further to ERK phosphorylation and subsequent phosphorylation of CREB and Elk1. 
Elk-1 is directly activated by MAPK/ERK and plays a pivotal role in IEGs induction (Hipskind 
et al., 1994; Marais et al., 1993) via its binding to Serum response elements.  
c-Fos and Bdnf transcriptions are triggered by really similar signaling cascade as Egr-1 apart 
the TORC mediated phosphorylation of CREB (Cortés-Mendoza et al., 2013)  
Indirect effect of APP 
We know that in APP transgenic mice, or in neurons treated with amyloid β oligomers, 
neuronal signaling is impaired due to impaired NMDARs activation and 
intracellular calcium mishandling (Bordji et al., 2011; Ferreira et al., 2012; Rush and Buisson, 2014). 
Indeed, it has been show that APP/PS1 mice have alterations of 
Ca2+/calmodulin/CaMKII/CaV1.2 signaling pathway with consequences of a decrease in BDNF and 
p-CREB expression (Min et al., 2013). Moreover, in primary cortical neurons expressing human 
APP, the frequency and amplitude of calcium oscillations are modified, suggesting a role for APP in 
maintaining neuronal calcium homeostasis essential for synaptic transmission (Santos et al., 2009).  
Those studies describe situations where APP is mutated or overexpressed and cannot fulfill its role 
of neuronal activity modulator effectively.  
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In our case, loss of function of APP in APP-/- mice could have a disturbing effect in on NMDA 
receptor activation or in the intracellular calcium homeostasis, disturbing the transcriptional 
pathway induced by neuronal-activity and the subsequent induction of IEGs. We suggest that up-
regulation of IEGs observed in APP -/- mice could be the consequences of an indirect effect of APP 
on gene transcription. Another indirect effect of APP could be the regulation of ARC. As shown in 
the second article, ARC expression is dependent of APP but the level of histone H4 acetylation in 
ARC promoter is not different in APP-/- PFC, contrariwise to Egr-1, c-Fos and BDNF. This suggests 
that ARC is not regulated by the same activator/repressor complex as the other IEGs. One 
possibility is that ARC overexpression in APP-/- is a consequence of Egr-1 up-regulation in those 
mice, as Arc is a direct target gene of Egr-1 (Li et al., 2005). This hypothesis is described in figure 
20. 
 
Regulation of IEGs by APP: are other partners involved?  
In our study, we decided to focus only on the CREB dependent activation of Egr-1 but it seems 
obvious that the regulation of Egr-1 could also occur through other transcription factors (TF) 
(figure 21). Even if CREB is the main activity-regulated transcription factors regulating IEGs 
transcription, the promoters of Egr-1 and c-Fos contain response elements for ELK1, SRF and AP-1 
transcription factors. Analysis of the presence of these transcription factors  at IEGs genes 
promoter in APP+/+ and APP-/- mice PFC would be really interesting to describe precisely if the 
action of APP is specific to CREB or if APP acts globally on IEGs induction cascade. 
Figure 20 : Schematic representation of indirect regulation of IEGs by APP trough calcium signaling. A. 
In APP +/+ neurons, APP regulates the Ca2+ balance in the cell with consequences on the pathway of 
induction of IEGS. In B.APP -/- neurons, this balance is impaired leading to an up-regulation of IEGs but 
also to the disability of the cell to induce them properly upon stimulation.   
B A 
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Moreover, we took the decision to analyze the presence of HDAC2 due to its involvement in the 
regulation of IEGs on the contrary to HDAC1 (Guan et al., 2009) but it is sure that HDAC2 is not the 
only repressor active in this regulation and the analysis of the presence of other HDACs or 
inhibitory complex as mSin3a or CoRest at gene promoter would be of a great interest. In the 
same way, a closer look at the other HAT, and especially CBP/P300, on gene promoters would be 
relevant.  
 
 
 
 
 
 
 
 
Direct effet of APP :  AICD mediates the regulation of  IEGs by moving HME at gene 
promoters 
 One of the first hypotheses suggested for the epigenetic regulation of Egr-1 and c-Fos 
characterized by a higher level of acetylated histone H4 at gene in promoters in APP-/- neurons 
and cortex extracts was the possibility of the AICD present in the nucleus to interact with HME and 
displace, or recruit some of them in order to regulate gene transcription. In the figure 22 A , I 
represented AICD located at Egr-1 gene promoter and impairing CREB recruitment. The right panel 
schematizes the situation in absence of APP, where CREB is more recruited at the promoter of Egr-
1.  
As change in histone H4 acetylation is not mediated by a change in CREB recruitment, but by a 
removal of HDAC2 in APP-/- cortex, I could suggest that in that situation, AICD is able to recruit this 
HDAC at c-Fos promoter, and absence of AICD is associated with a lack of HDAC2, explaining the 
higher level of expression of c-Fos in APP-/- (Figure 22B). 
Figure 201 . Schematic representation of the hypothetical interaction of APP itself of through its 
fragments with other transcription factors with consequences on IEGs regulation 
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However this hypothesis is challenged by several conflicting results. First, treatment with gamma 
secretase inhibitor that impairs AICD production, don’t change the level of Egr-1 expression in 
neurons suggesting that APP-dependent regulation of Egr-1 is AICD and Aβ independent. Second, 
we failed to immunoprecipitate AICD at gene promoters. Given the small size of this intracellular 
domain and the difficulty to detect such small molecule in a bigger complex, this cannot absolutely 
refute the possibility of the presence of AICD at gene promoter, but for now, we think that AICD 
dependent regulation of IEGs is not likely. Moreover, we failed to detect any direct interaction 
between AICD and CBP and HDAC2 in immunoprecipitation assays, supporting this AICD 
independent mechanism  
 
Figure 22. Direct effect of AICD on gene transcription. A left panel:  In presence of APP, interaction of AICD 
with Egr-1 promoter can lead to a decrease in CREB enrichment and the subsequent repression of gene 
transcription, absent in APP -/-  (A right panel), while c-Fos regulation by AICD could be due to the ability 
of AICD to recruit HDAC2 on the gene promoter (B left panel) leading to a greater CREB recruitement in 
APP -/- (B right panel). This hypothesis is severely challenged by our results for now. 
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Direct effect of APP: interaction with epigenetic partners 
Specificity of APP on IEGs regulation is not easy to understand. As we did not observed general 
changes in the global amount of HDAC2, P-CREB, total level of histone H3 and H4 acetylation, nor 
any interaction between APP and HDAC2 or CBP by co-immunoprecipitation assay (data not 
show), we assume that APP affects expression of IEGs at other level. The hypothesis of a direct 
effect of APP on IEGs is not very likely because the only part of APP able to enter the nucleus to 
regulate gene transcription is the AICD, and we showed earlier that Egr-1 expression did not 
depend on AICD. Another possible hypothesis is that APP promotes the transport of HDAC in the 
nucleus in resting condition. This could be related as with the work of Mastroeni et al. that 
suggests that Aβ triggers deficit in transport of HDAC and DNMT in the nucleus by inhibiting a 
nucleocytoplasmic transporter (RAN) (Mastroeni et al., 2013). In our case, physiological APP could 
promote the transport of histone modifying enzymes as HAT or HDAC in the nucleus (figure23). 
 
 
 
 
 
 
 
 
C. Physiological relevance of APP-mediated regulation of Egr-1 
After analyzing the expression of Egr-1 in resting mice, we soon questioned ourselves how this 
expression would behave following stimulation. Indeed, triggering IEGs expression is one of the 
main mechanisms underlying consolidation of memories (Bozon et al., 2002; Bozon et al., 2003b; 
Figure 23. APP itself or its intracellular fragments (only AICD and Aβ  are schematized here) could 
promote or inhibit the transfer of histone modifying enzymes in the nucleus, regulating IEGs 
expression.  
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Guzowski et al., 2001; Jones et al., 2001) and IEGs expression occurs in a time dependent manner 
in the brain after stimulation  (Bozon et al., 2003a; Kubik et al., 2007). 
In order to answer this question, we established a protocol of Egr-1 induction based on the 
literature (Dickey et al., 2004; Sarantis et al., 2012). Among the different options available, we 
decided to go further with a smooth and simple protocol of exposition to novelty in an open field 
easy to realize and reproduce.  
As APP -/- showed a greater expression of Egr-1 in PFC and hippocampus, we imagined that Egr-1 
induction could have been better in those mice. However, after results analysis we observed that, 
on the contrary, Egr-1 was not induce at all in APP-/- mice, while we observed a two time increase 
of Egr-1 expression in PFC of APP +/+, validating the protocol of induction.  In the literature, 
induction of IEGs upon stimulation in APP -/- mice has never been studied, but it was the case in 
APP transgenic mice, giving us ideas in results interpretation. In this part, I will review what we 
know about Egr-1 expression and induction in AD mouse model in relation with what we observed 
in APP -/-mice. 
IEGs expression and induction in APP transgenic models 
First analysis of IEGs expression in APP transgenic mice (APP/PS1) was done by Dickey et al in 
2003. By a microarray analysis, they detected a reduced mRNA expression of several genes 
essential for long-term potentiation and memory formation of which Egr-1 and Arc. They related 
this decrease in IEGs expression to Aβ presence because Egr-1 down-regulation was more drastic 
near amyloid plaques (Dickey et al., 2003). In another study of the same group, the reduction of 
Egr-1 in APP/PS1 mice decreased capabilities of experience-dependent induction of this gene. 
Indeed, induction of Egr-1 expression in the hippocampus had a trend to be altered when 
measured 30 min after exposure of 18-month-old APP + PS1 transgenic mice to a novel 
environment (Dickey et al., 2004). On the contrary, Lazarov et al. showed that in the context of 
environment enrichment, APP/PS1 mice were still able to induce Egr-1 contributing to the positive 
effect of EE on memory (Lazarov et al., 2005).  
The work of Blanchard assessed the level of Egr-1 induction in two sets of mice APP 751SL at 
different ages (5-6 and 7-8 moa) after several trials in Morris Water Maze. Interestingly, they 
showed that learning-dependent Egr-1 induction was clearly reduced in the hippocampus of the 
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7–8-month-old APP751SL mice when the animals were killed 90 min after testing. They conclude 
that APP overexpression affects plasticity mechanisms in hippocampus leading to deficits of spatial 
memory and this could explain the cognitive defects described in APP751SL mice (Blanchard et al., 
2009).  
Down-regulation of Egr-1 in APP transgenic mice in different brain regions was confirmed in 
different models recently.  According to Koldamova, protein levels of Egr-1 and Arc are 
significantly lower in the brain than in age-matched wild type animals and Egr-1 is able to regulate 
APP by binding to its promoter (Koldamova et al., 2014). In parallel, expression of Egr-1 and Arc 
was not impaired in 3- and 6-month-old APPSwe/PS1 mice compared to APP +/+ but decreased 
signal for Egr-1 and Arc was showed by in situ hybridization at 6 moa and confirmed by RT-PCR 
analysis (Naert and Rivest, 2012). 
So, from these observations, mice carrying pathogenic mutation of APP always show a decrease of 
IEGs expression, contrariwise to APP KO mice that show higher level of IEGs. That means that the 
loss of function of APP or overproduction of Aβ in the brain of these mice leads to a negative 
regulation of IEGS transcription.  
However, APP Tg and APP-/- mice have in common the impaired induction of IEGs necessary for 
memory formation, as well as memory deficits and impairments in LTP (Chong et al., 2011; 
Moechars et al., 1996; Pozueta et al., 2013; Trinchese et al., 2004). This suggest that induction of 
IEGs after stimulation is a major step in the memory processes and this major function of APP is 
lost in both transgenic  and KO mice.  
Unfortunately, all those models assess the induction of Egr-1 in hippocampus, and not in the 
prefrontal cortex. Then, it would be interesting to assess how Egr-1 and c-Fos are induced after 
exposure to novelty in the hippocampus of APP-/- mice. However, in light of those publications, it 
seems that impairment of Egr-1 induction is a key step underlying cognitive deficit in AD mouse 
model, and similar deficit in IEGs induction seen in APP -/- mice could explain partly the memory 
deficit observed in those mice. 
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D. General perspectives  
In the light of this work, we show that APP is able to regulate expression of several IEGs by 
epigenetics mechanisms and with physiological consequences in vivo. However, this work raises 
several questions regarding the complete mechanisms of action of APP. Here is a list of the major 
perspectives that we consider important for the further understanding of APP function in the 
brain.  
1. An analysis of APP dependent IEGs regulation of expression in other brain structures like the 
hippocampus is needed. Indeed hippocampus is the major area involved in memory 
formation. First results obtained at mRNA levels are encouraging but analysis of level of 
expression of IEGS, acetylation of histone surrounding their promoters and their expression in 
the hippocampus in context of novelty will be of a great interest.  
2. To investigate which domain of APP is involved in gene regulation and to overcome the 
compensatory effect of APLPs, it would be really interesting to analyze expression of IEGs in 
other models like cultured neurons from double KO APP/APLP2 mice or APPsα-Knock-In mice 
lacking transmembrane domain of APP and expressing solely the secreted APPsα fragment 
(Weyer et al., 2014) . Assessing the effect on gene transcription of α and β secretase inhibitors 
that prevent the production of APP soluble fragments could give some indication about the 
domain of APP involved in regulation of IEGs transcription. 
3. The use of pharmacological inhibitors targeting specific actors of the signaling cascade (for 
example MAPK as MEK, ERK) leading to IEGs expression could help us to discriminate some 
pathway by which APP regulates IEGs expression.  
4.  We assessed the recruitment of HDAC2 and CREB on IEGS promoters but these epigenetic 
actors are part of larger complexes, and the discovery of every members of these structures 
by other ChIP experiments with antibody targeting other HDACs, HAT or co-activators/co-
repressor molecules would be necessary. Moreover, we analyzed only a short sequence of Egr-
1 and c-Fos promoters, an epigenetic analysis of complete sections of each promoters is 
necessary. Based on literature, we focused our work on histone acetylation analysis, but an 
analysis of methylated positions at IEGs promoters would also be interesting. 
5. As an indirect effect of APP due to an imbalance of Ca2+ signaling is plausible, a further 
analysis of Ca2+ oscillation in neurons expressing or not APP, and the reaction of these 
oscillations after treatment with HDAC inhibitors is relevant.  
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6. During this work, we choose a simple behavioral test of exposition to novelty in young APP -/- 
mice. As APP-/- mice show memory deficits at old age, it would be interesting to understand 
how APP dependent regulation of IEGs occurs with ageing. Moreover, a large range of 
behavioral tests specific to every types of memory exists and a more complete analysis of the 
behavior of APP-/- mice in these tests, in relation to IEGs induction would be necessary. 
E. Expression of Egr-1 in Alzheimer’s disease  
Egr-1 expression in the brain of AD patients was investigated by us and others. As shown in the 
first article, Egr-1 was strongly increased at protein levels in AD temporal cortex. Egr-1 up-
regulation at mRNA and protein level was first described in CA1 region of hippocampus of AD brain 
by Mac Gibbon et al (MacGibbon et al., 1997). Later, a microarray analysis on AD brain at different 
stage revealed an overexpression of Egr-1 in severe AD brain (Gómez Ravetti et al., 2010), and 
similar observation was done at protein level by Lu (Lu et al., 2011).  
As Egr-1 transcription factor regulates numerous AD related genes, overexpression of Egr-1 could 
have detrimental consequences during the pathology.  Indeed, Lu et al. showed that Egr-1 was 
regulating Cdk5, a kinase regulating Tau phosphorylation, and that Egr-1 aberrant expression could 
lead to the accumulation of hyperphosphorylated Tau (Lu et al., 2011). Moreover, Egr-1 is known 
to regulate other protein up-regulated in AD as p53 (Hooper et al., 2007; Krones-Herzig et al., 
2003; Liu et al., 2001) or involved in APP processing like the human an murine PSEN2 gene 
(Ounallah-Saad et al., 2009; Renbaum et al., 2003). 
Egr-1 overexpression in AD brain could result from a compensatory effect of the surviving neurons 
in order to improve memory processes. 
Another hypothesis in accordance to our observations is that the up-regulation of Egr-1 seen in AD 
and in APP -/- mice is a consequence of a loss of function of APP, with consequences on Egr-1 
target genes expression and deficit in memory formation.  
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